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Skin-lightening products are widely used in South Africa by the Indian and African 
communities.  The main purpose of these products is to lighten the skin as well as to 
even out skin tone or treat pigmentation disorders such as freckles, melasma, pregnancy 
marks and age spots.  These products are widely available as over-the-counter cosmetics 
and only a few are available by prescription only.  The active ingredients in these 
products act on the tyrosinase enzyme to prevent melanin formation.  Different skin-
lightening agents (SLA) have different effects on the skin; some are harmful to the skin 
whereas some can be used without detrimental effects. 
In some countries, those SLA which are harmful to the skin have either been 
banned or had limits imposed on the amounts which can be used.  These include 
compounds containing mercury, glucocorticoids and hydroquinone.  An alarming 
number of women present themselves at dermatology clinics with permanently 
damaged skin as a result of the use of over-the-counter preparations and products sold 
by street vendors.  In this study a number of preparations bought in the market in 
Durban were investigated. 
Reversed-phase high performance liquid chromatography (HPLC) with both 
ultraviolet and fluorescence detection was used.  Phenolic and steroid standards were 
used to qualitatively identify the active ingredients.  A method was developed for the 
extraction of SLA in the creams and also for their quantification by means of HPLC.  A 
total number of 35 skin-lightening preparations were qualitatively analysed, and it was 
found that 11 samples had skin-lightening agents based on the standards that were used. 
From the samples analysed it was found that one sample contained phenol, five 
samples contained arbutin, and three samples contained benzoquinone and 
hydroquinone, whereas two samples were found to contain niacinamide.  The samples 
containing hydroquinone were found to also contain benzoquinone because the 
hydroquinone hydrolysed into benzoquinone.  The benzoquinone concentrations could 




The concentration of phenol found in sample 1 was 0.655 ± 0.026% (m/m).  The 
amounts of arbutin found in the samples (5, 6, 8, 9, and 16) were found to be between 
0.291-2.498% (m/m).  The amount of niacinamide was found to be 0.751 ± 0.025 and 
1.049 ± 0.225% (m/m) for sample 27 and 26 respectively.  The concentration of 
hydroquinone was found to be, 1.255 ± 0.070, 2.224 ± 0.019 and 1.853 ± 0.029% (m/m) 
for sample 22, 23 and 24 respectively.  The skin-lightening agents, phenol and 
hydroquinone, are banned in South Africa therefore those samples containing this SLAs 
are illegal.  Limits for niacinamide have not been determined and arbutin was within the 
limits.  The %RSD of the samples was between 0.009-8.900% which is acceptable. This 
shows that the method can be reproducible for the different samples with a good 
precision. 
A method for gas chromatography coupled with a mass detector (GC-MS) was 
developed.  The method was used to analyse phenolic standards which were first 
derivatised by using N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA).  The method 
was able to separate a mixture containing resorcinol, hydroquinone, kojic acid and 
arbutin.  The method failed to detect the SLAs in the skin-lightening products.  GC-MS 
failed to confirm the presence of phenolic SLAs detected with HPLC. 
The second part of the research involved an investigation of the clays which are 
used by Xhosa and Zulu women as sunscreens and also for skin-lightening purposes.  
Two types of clays were analysed: a red and a white coloured clay.  The functions of 
clays are determined by their different physical properties.  The compositions of the 
clays were determined by means of powder x-ray diffraction (XRD) and x-ray 
florescence (XRF).  XRD gave two different diffactograms.  XRF gave the major oxides 
in the clays.  The clays had the same oxides but in different amounts.  The red clay 
contained more iron(ΙΙΙ) oxide, while the white clay contained much less but had a 
higher amount of quartz.  The results from XRD were in agreement with those from 
XRF.  It was found that the clays were not only made of clay minerals, but also 
contained impurities.  They contained a significant amount of titanium dioxide which is 
used in sunscreens.  The clays were identified as kaolinite (white clay) and iron stained 
kaolinite (red clay).  Further confirmations of the composition of the clays were 
obtained by using thermogravimatric analysis (TGA), infrared spectroscopy (IR) and 
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transmission electron microscopy (TEM).  The sun protection factor of these clays was 
low (approximately 4) but they offer a cheap alternative to the more expensive products 






The experimental work described in this dissertation was carried out in the School of 
Chemistry and Physics, University of KwaZulu-Natal, Durban under the supervision of 
Professor Bice S. Martincigh. 
 
These studies represent original work by the author and have not otherwise been 
submitted in any form for any degree or diploma to any tertiary institution.  Where use 
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In life people want to look their best.  In particular, women want to appear 
beautiful and this has led to the growth of the cosmetic industry and it continues to grow 
each year.  The beauty industry is composed mostly of cosmetics and skin care 
products. 
Westerners consider a tanned skin beautiful [1] whereas for African women 
beauty is associated with light skin.  When a women is dark skinned, society has made 
them believe that they are ugly and need to be light to be beautiful.  This has led to an 
obsession with beauty, more especially with women all over the world and has made the 
market for skin-lightening creams big and profitable.  The production and marketing of 
skin-lightening products (SLPs) has become a multi-billion-dollar global industry [2].  
Women in Asia are deeply influenced by the concept that a lighter complexion has the 
power to hide a number of faults [3].  In South Africa the concept of “Yellow bones”, 
which refers to very light skinned ladies, has been making the rounds as men now prefer 
those ladies compared to the dark skinned ones.  A women’s worth is judged based on 
the way she looks, and skin colour is used to judge the attractiveness of women [2].  
Khessal is the process of voluntary depigmentation which is widespread in sub-Saharan 
Africa [4]. 
Companies spend a lot of money in research and development so as to find ways 
to lighten the skin that are not harmful in the long run.  A lot of money is also used in 
advertising and marketing of skin-lightening creams (SLCs) [2].  This industry has also 
given way for some smugglers, transitional migrants and petty traders to take the 
opportunity to illegally produce, transport and sell unregulated lightening products [2]. 
1.1 Skin-lightening creams and their uses 
Skin-lightening creams are creams made with the purpose of lightening the skin.  
They usually contain an active ingredient that does this.  These are called skin-
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lightening agents (SLAs). Skin-lightening agents have different mechanisms of action to 
lighten skin depending upon what class of compound they are. 
People use these creams because they have been led to believe that light skin is 
more beautiful than dark skin, so obsession with beauty is their main motivation.  Other 
reasons for using skin-lightening agents include to even out skin tone and to treat 
pigmentation disorders such as freckles, melasma, pregnancy marks and age spots [5].  
Such pigmentary disorders have an impact on people’s quality of life [6].  Some skin-
lightening creams claim to have oil catchers and as a result some women use them to 
prevent their face from being shiny throughout the whole day.  Skin-lightening creams 
are commonly used by the sub-Saharan African [7] and Asian populations.  People 
continue applying the creams so as to ensure their skin does not go back to the previous 
state [8], and therefore there is a practice of long-term use. 
1.2 Skin lightening agents 
Skin-lightening agents (SLAs) are compounds which are used to treat skin 
pigmentation disorders like hyperpigmentation and freckles.  Brown spots and skin 
blemishes occur as a negative result of ultraviolet (UV) radiation and therefore make the 
production of skin-lightening agents important to help reduce such skin problems [5].  
SLAs are classified into different classes based on the type of compounds they are made 
of. 
1.2.1 Phenolics 
Phenolics are compounds which have a phenol group in them (Figure 0.1) and 
are used as skin-lightening agents.  Compounds like phenol, hydroquinone and 
resorcinol are a few examples that have been used in skin-lightening creams.  
Hydroquinone, for example, has been proven to be successful as a skin-lightening agent 












Figure 0.1  Examples of some phenolics used as SLAs: hydroquinone, phenol and resorcinol. 
Hydroquinone is the gold standard for skin-lightening and it is the most 
frequently prescribed in the world [9].  It has been widely used for the treatment of 
melasma, inflammatory hyperpigmentation and other hyperpigmentation disorders [10].  
Depigmentation of the skin is usually observed within 4 to 6 weeks of using products 
containing hydroquinone as the only SLA in the product [10].  It can be found in 
products in combination with tretinoin, glycolic acid, vitamin C, retinol and fluorinated 
steroids [10]. 
1.2.2 Steroids 
Steroids are useful in treating some of skin disorders, such as eczema and 
psoriasis.  They are found to be effective but their unmonitored use may lead to many 
problems.  They are usually used in high dosages to treat such skin disorders and it is 
essential that doctors’ orders are followed in terms of their use.  The strongest topical 
steroids (Figure 0.2) used include betamethasone dipropionate, clobetasol propionate 
and fluocinonide [8].  Betamethasone, dexamethasone, hydrocortisone, fluocinolone, 
triamcinolone and other corticosteroids are used in combination with other skin-





























Figure 0.2  Structures of some of the strongest topical steroids used in the SLPs market: 
betamethasone, clobetasol propionate and fluocinonide. 
1.2.3 Plant extracts 
Plant extracts are used in skin-lightening creams as the industry attempts to 
move towards a more natural solution.  There are contrary effects associated with the 
use of artificial chemicals and this has made the move towards the development of 
natural ingredients in skin care products [12].  These compounds are usually found in 
nature.  Kojic acid and arbutin (Figure 0.3) are some of the compounds that have been 
found in plant extracts and have the ability to lighten skin.  Kojic acid is derived from 
fungi species whereas arbutin can be derived from the bearberry plant, certain herbs and 
pear trees [10].  Melanin formation inhibitors, which are more effective than 
hydroquinone, have been found to be these plant extracts which do not exhibit 
cytotoxicity or mutagenicity of melanocytes [13].  These compounds and their 














Figure 0.3  Some of the SLAs found in plant extracts used in SLP: kojic acid and arbutin. 
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Some of the natural SLAs include aloesin, azelaic acid, glycolic acid (from sugar 
cane), licorice extract and soy.  Aloesin is a natural derivative of aloe vera [14] which is 
still an experimental product and is not available clinically [10].  Aloesin has a unique 
ability as it acts as a competitative inhibitor of Dopa oxidation and as a noncompetitor 
to tyrosine hydroxylase activity [10, 14]. 
Azealic acid is a naturally occurring dicarboxylic acid derived from 
pityrosporum ovale [10].  Azealic acid has a great effect on heavily pigmented 
melanocytes but has a minimal effect on normal pigments [10].  It can be used for 
extended periods as it is well tolerated by the skin [10, 11].  It is available by 
prescription in the strength of 15 to 20 % in the United States [10]. 
Glabridin is an active compound in licorice extract and it is used in 
concentrations of 10 - 40 % in SLCs [10].  It has fast action as depigmentation results 
can be seen within a week of use [10]. 
Natural soyabeans contain Bowman-Birk inhibitor and soy-bean trypsin 
inhibitor, two serine protease inhibitors that interfere with the protease-activated 
receptor 2 path way [10].  It is safe and effective [10].  Unpasteurized soy milk needs to 
be used for it to be effective [10].  It is available in the market in products that improve 
mottled hyperpigmentation and solar lentigines [10]. 
There are botanical extracts which contain a combination of two or more classes 
of compounds that achieve skin-lightening by working synergistically [15].  Botanicals 
are from nature, and this makes then more acceptable to people [15].  Botanical extracts 
could even be from indigenous knowledge which is passed down generations.  This has 
led to products being labelled exotic because they have certain botanical extracts [15].  
It should be noted, however, that not all natural extracts are stable and can be 
compatible in SLP formulations [15]. 
1.2.4 Vitamins 
The research into skin care products that are more effective has resulted in 
products that will not only improve the appearance of the skin, but the health of the skin 
as well [16].  This has resulted in research into the incorporation of vitamins and 
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antioxidants in cosmetics.  There are some vitamins which are used as SLAs in 
cosmetics creams.  Niacinamide, a form of vitamin B3 (Figure 0.4), is among one of the 
most used SLAs in creams.  It has been shown to improve acne due to its anti-
inflammatory properties[16].  It has also been suggested that it can possibly also have 
some photoprotective effects due to its antioxidant activity [16].  
Vitamin C, which is very important due to its ability to quench uv-induced free 
radicals directly, is also considered as an antiaging ingredient [16].  In cosmetics it is 
found in three forms.  It can be found as ascorbyl palmitate (Figure 0.4) which is 
considered a lipophilic whitening agent [1, 16, 17].  It is also found as magnesium 
ascorbyl phosphate and L-ascorbic acid [16, 17] which are hydrophilic whitening agents 
[1].  These compounds are used in the chemical peeling process, which entails their 
application as a therapeutic agent for damaged facial skin arising from acne, melasma, 
and common warts and so on [1].  This results in the skin becoming lighter and 












Ascorbyl palmitate  
Figure 0.4  Structures of niacinamide and ascorbyl palmitate some of the vitamins used as 
SLAs. 
1.2.5 Combination of SLA therapy 
Skin-lightening agents need to be effective and also have little to no side-effects 
[18].  The major problem encountered with the use of one SLA is that they fail to meet 
the requirements of being a good SLA.  This has led to the development of 
combinations of SLAs which produce a synergistic hypopigmenting effect [18].  The 
combinations of SLAs have been determined by clinical trials.  When the use of 
hydroquinone is alternated with any plant extract, combined with steroids or in 
sequential applications, the side effects caused by hydroquinone are minimised [18].  
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Hydroquinone 5%, tretinoin 0.1% and dexamethasone 0.1% (Kligman’s formula) is the 
most commonly used combination in treatments [18].  Dexamethasone decreases the 
side-effects of hydroquinone [18].  Tretinoin reduces the side-effects caused by using 
corticosteroids and improves the penetration of SLAs into the stratum corneum [18].  
There are many more combinations that are have been developed via clinical trials [18]. 
1.2.6 Mercury 
Mercury has been used in SLPs.  Mercury exists in the inorganic, elemental and 
organic form.  Mercury is poisonous and can be absorbed as vapour or through the skin 
and gastrointestinal tract as finely dispersed granules which can be excreted through the 
kidneys and colon [8].  During the first decade of the 20th century, mercurious chloride, 
oxide and ammoniated mercury were introduced as active ingredients in toiletries and 
cosmetics [8].  Eventually, they became popular skin-lighteners [8].   
1.3 Mechanism of skin lighteners 
Pigmentation of the skin is caused by the amount, quality and distribution of 
melanin, which is the naturally occurring pigment in the skin [4, 19].  Melanin is 
synthesised by large dendric cells known as melanocytes which are located at the 
epidermal-dermal junction [20].  Melanin production is the major source of skin colour 
and plays an important role in protecting human skin from the harmful effects of UV 
radiation from the sun [3].  Solar UV radiation, toxic drugs, hormones and chemicals 
are some of the environmental factors than can increase melanin production [20].  There 
are also genetic factors that affect its production.  The major source for skin 
pigmentation is UV radiation. 
Melanin in the skin is catalysed by solar UV radiation. It causes the cytokine 
growth factors and other inflammatory factors to be released by fibroblasts to stimulate 
melanin production [3].  The melanocytes increase the production of intracellular nitric 
oxide (NO), which triggers signal transduction cascades to initiate melanogenesis 
through the tyrosinase enzyme, a copper-containing oxidase [3].  Tyrosinase in 
melanocytes is a key enzyme in the synthesis of melanin pigments (Figure 0.5) [5, 19, 
20].  Melanogenesis is the whole process which leads to the formation of dark 




Figure 0.5  Scheme of melanogenesis [3].   
Although melanin mainly has a photoprotective function in human skin, the 
accumulation of an abnormal amount of it in different specific parts of the skin resulting 
in more pigmented patches might become an aesthetic problem and cause a 
dermatological issue [3, 19].  Examples of conditions caused by over production of 
melanin include, but are not limited to, tanning, melasma, chloasma, freckles, age spots 
or uneven skin tone [4, 20].  It is due to this factor that skin-lightening agents where 
developed and are now used throughout the world.  The function of the SLAs is to 
prevent and block the accumulation of melanin [19]. 
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Although there are a lot of mechanistic points that can be targeted, tyrosinase 
inhibition is the most common approach to achieve skin whitening.  The development 
of successful whitening skin care products depends on the use of effective whitening or 
depigmenting ingredients that inhibit melanin formation in melanocytes [20] but do not 
stop the production of melanin indefinitely [19]. 
Hydroquinone inhibits melanin production by acting as a substrate for tyrosinase 
and inhibiting sulfhydryl groups [8, 19, 22].  The mode of action of mercury includes 
the inactivation of the sulfhydryl enzymes called mercaptans [8].  Mercaptans are able 
to capture mercurial ions which then compete and replace copper in the tyrosinase 
molecule thereby deactivating the molecule [8].  This process interrupts the production 
of melanin [8].  
Corticosteroids inhibit endogenous steroid production and thus decrease the 
propiocortin hormone thereby lightening the skin [8]. 
Arbutin works as a skin-lightening agent by inhibiting the conversion of tyrosine 
to melanin [23].  It hinders the oxidation of L-dopa to L-dopaquinone by competing 
with L-dopa for the receptor site on tyrosinase [24]. 
Kojic acid’s activity is attributed to the ability to bind to copper and thereby 
reducing tyrosinase activity [22]. 
1.4 Regulations governing the use of skin-lightening creams 
There are regulations which have been set in terms of what skin-lightening 
agents are allowed and in what quantity they are allowed.  The National Food and Drug 
Agency of Nigeria has banned all bleaching agents in cosmetics and toiletries due to the 
long-term effects they have on the skin and also the noncompliance in terms of labelling 
requirements [8]. 
1.4.1 Hydroquinone 
Hydroquinone has set limitations all over the world.  A set limit of 2% for over-
the-counter cosmetics has been set in the Republic of South Africa [25] and the United 
States of America, whereas in the European Union it has been banned from all over-the-
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counter products and can only be found in prescription products [4].  It is stated that 
hydroquinone products have been banned in Nigeria and South Africa [2]. 
1.4.2 Phenol 
Phenol is used as a skin disinfect in a solution of 3-5% [4].  Phenol is banned in 
South Africa. 
1.4.3 Arbutin 
Arbutin can be classified as a plant extract as it can be isolated from the 
bearberry plant [13, 23].  It is a glycoside derivate of hydroquinone [5, 13] and therefore 
has a chemical structure that is similar to that of hydroquinone.  The allowable amount 
of arbutin is 7% [23]. 
1.5 Side-effects of prolonged usage of skin-lightening creams 
Hydroquinone is the most commonly used skin-lightening agent which is 
effective [4], however, it is very unstable as it is oxidised rapidly [18].  Prolonged usage 
of hydroquinone may cause exogenous ochronosis which is in fact further pigmentation 
of the skin [2, 4, 8, 10, 13, 18].  People that use the hydroquinone products and live in 
sunny climates are more at risk of getting exogenous ochronosis [10].  Other reported 
dermatological complications include dermatitis, cataracts, pigmented colloid milia, 
sclera disorders, nail pigmentation and patch depigmentation [4, 8, 13, 18].  It is due to 
these side-effects that there are regulations set.  When such complications arise, people 
tend to use the SLAs more in the hope that the complications will clear out [8].  The 
most common side-effect of using hydroquinone are skin irritations and contact 
dermatitis, which can be treated with topical steroids [10].  It is for this reason that some 
products containing hydroquinone as an active ingredient also have topical steroids so 
as to minimise any side-effects from using the product.   
Phenol has a minor degree of whitening effect [4]. Prolonged exposure greatly 
irritates and harms the skin [4]. 
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Arbutin in acidic conditions hydrolyses to D-glucose and hydroquinone and 
therefore presents the same health effects of those of hydroquinone which are not 
desired [24]. 
Topical steroids when misused as skin-lightening agents have secondary effects 
which include skin thinning and also increased infection rates [26].  This is due to the 
fact that steroids only relieve inflammation on skin but do not kill bacteria; in fact the 
breeding of bacteria is actually promoted [26].  Skin thinning results in the swelling of 
fine blood vessels (telangiectasia), temporary loss of pigment in the areas of treated 
skin, perioral dermatitis (rash around the mouth), permanent stretch marks (striae) and 
enlarged blood vessels (telangiectasia) [26, 27].  The side-effects of steroids are 
dependent on the nature of the skin problem, the site treated, the strength of the steroid 
and the length of application [26, 27].  The application of potent to moderately potent 
glucocorticosteroid preparations to the neck, facial skin and scrotum or vulva for a 
period of one month can result in steroid addiction syndrome [8].  Severe burning 
occurs when steroids are no longer applied to such skin tissues which can only be 
stopped by further applications of steroids [8].  This is because those skin tissues are 
addicted to the steroids [8]. 
Mercury is highly toxic.  The use of mercury as a skin-lightening agent can lead 
to its accumulation in the body and this can cause neurological damage and kidney 
disease [2].   
1.6 Methods of analysis of skin-lightening agents 
Skin-lightening agents such as mercury and hydroquinone have been analysed 
for many years since their side-effects where first recorded.  An increase in new skin-
lightening creams and agents has led to a demand of constantly new procedures to 
quantify such compounds.  Methods which have been used over the years for analysis of 
skin-lightening agents include, gas chromatography (GC), spectrophotometry, thin layer 
chromatography (TLC), capillary electrophoresis (CE), capillary electrochromatography 
(CEC), micellar electrokinetic chromatography (MEKC), electrochemistry, differential 
pulse voltammetry (DPV) and high performance liquid chromatography (HPLC) [28-
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30].  Mass spectrometry is also used for the analysis of skin-lightening agents coupled 
with either HPLC or GC [29]. 
Chisvert et al. proposed a method to determine the quantity of kojic acid, azelaic 
acid, arbutin, resorcinol and hydroquinone in skin-whitening agents in cosmetics using 
GCMS [31].  The target analytes were derivatised due to their low volatility.  It was 
reported that this was the first official analytical method in literature except for those 
proposed by the EU commission and the United States Pharmacopeia [31]. 
Gaudiano et al. have reported on an HPLC method for the determination of six 
different glucocorticoids simultaneously and the method was used to identify 
counterfeit products from Europe [28].  HPLC is one of the most used instrumentation 
methods in the analysis of SLAs.  The method is important as it allows for the 
simultaneous analysis of six glucocorticoids.  
A flow-injection method has been reported for the analysis of arbutin in SLPs 
and also extracts [5].  The method has been reported as being fast, accurate, sensitive 
and simple [5]. 
1.7 Extraction of skin-lightening agents 
Before SLAs can be identified and quantified they need to be quantitatively 
extracted from the product by a suitable method.  Vortex mixing of the samples in the 
mobile phase has been a common way to extract the SLAs in the creams [5, 12, 32].  
Depending on the SLA of interest, samples would undergo filtering or centrifugation 
[32].  Vortex mixing has been coupled with ultrasound and heating in a water bath in 
order to assist with the extraction [28, 33].  Depending on the SLAs of interest, the 
sample will undergo some or all of the steps once or several times. 
Samples are also homogenised in specific solvents and then ultra-sonication is 
used to assist in the extraction of the SLAs in the samples [17, 23].  Heating a dissolved 
sample in a water bath and then followed by centrifugation has also been used to extract 
SLAs [30].  All samples prepared for HPLC are filtered through a 0.45 µm syringe filter 
before injection into the HPLC. 
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1.8 HPLC methods of analysis for skin-lightening agents 
The instrumental method chosen to separate, identify and quantify the SLAs in the 
selected products in this work was reversed phase HPLC.  A number of methods have 
been previously reported. 
Gaudiano et al. reported on an HPLC method where six glucocorticoids (methyl- 
prednisolone acetate, fluocinonide, dexamethasone, clobetasol propionate, 
betamethasone dipropionate and fluocinolone acetonide) were analysed [28].  The 
samples were extracted by using methanol as a solvent.  Chromatographic separation 
was obtained by isocratic elution with a Symmetry C18 column (Waters Corporation, 
MA, USA) with a mobile phase of water/acetonitrile (50:50, v/v).  The detection 
wavelength was 240 nm.  The method was reported to be robust, linear over a wide 
concentration range and sufficiently accurate and precise [28].  The method can be used 
to simultaneously analyse for the presence of the six glucocorticoids in commercial 
products. 
Huang et al. developed a method for the simultaneous determination of five 
whitening ingredients (magnesium ascorbyl phosphate, ascorbyl glucoside, kojic acid, 
arbutin and hydroquinone decomposed from arbutin in cosmetics) [23].  Samples were 
extracted with 0.05 M KH2PO4 buffer solution (pH 2.5) and analyzed with a Cosmosil 5 
C18-AR-II column [23].  A mixture of 0.05 M KH2PO4 buffer solution (pH 2.5) and 
methanol (99:1, v/v) was used as mobile phase [23].  The UV detector was set at 280 
nm [23].  Recoveries of these five ingredients spiked into a sample ranged from 93.5% 
to 103.3% [23].  The relative standard deviations of average recoveries were less than 
1.3% [23].  The limits of quantitation in cosmetics were 80.0, 20.0, 3.0, 15.0 and 10.0 
µg/mL for magnesium ascorbylphosphate, ascorbyl glucoside, kojic acid, arbutin and 
hydroquinone, respectively [23].  The purpose of this study was to develop a rapid and 
simple quantitative method for the simultaneous determination of above five ingredients 
in cosmetic samples using HPLC with a photodiode array detector (PDA) [23]. 
Sotofattori et al. reported on an HPLC method for the simultaneous determination 
of magnesium ascorbyl phosphate, imidazolidinylurea, a mixture of methyl-, ethyl-, 
propyl-, butyl- parabens dissolved in phenoxyethanol, and ascorbyl palmitate, by using 
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a cyano-propyl column and a methanol gradient at 220 and 240 nm [33].  Linear 
regression analysis of the data demonstrated the efficiency of the method in terms of 
precision and accuracy [33].  They claimed that this was the first time in literature 
where the simultaneous HPLC determination of such ingredients is reported [33]. 
Balaguer et al. developed a method they called environmentally friendly for the 
determination of ascorbic acid (vitamin C) and its derivatives (ascorbyl phosphate (as 
magnesium or sodium salts) and ascorbyl palmitate, and ascorbyl glucoside) in skin-
whitening cosmetics [17].  A C18 stationary phase and a mobile phase gradient of 
ethanol: 50 mM phosphate buffer at different pHs (containing 0.1 M NaCl) were used 
[17].  Detection was carried out with a UV/visible spectrometry detector set at different 
wavelengths [17].  The method was able to separate all analytes at good resolution [17]. 
Lin et al. used microdialysis sampling combined with HPLC for the determination 
of hydroquinone [34].  HPLC was conducted with a Hypersil Fluophase PFP column, 
the mobile phase was a solution of methanol (40%, v/v) in phosphate buffer (pH 5.50, 
0.020 M) [34].  The proposed method has easy sample pretreatment, rapid isolation and 
it is said to have a lower organic solvent consumption as compared to other methods for 
analysis of hydroquinone in cosmetic samples [34]. 
García et al. reported on an HPLC and an ultraviolet derivative 
spectrophotometric (UVDS) method for the quantitative determination of hydroquinone 
in gels and creams containing this compound as a unique active ingredient [35].  The 
HPLC was carried out by using a mobile phase constituted of methanol and water 
(20:80, v/v), and detection was made at 289.0 nm [35].  A Lichrospher® 100 RP-C18 
column (125 mm × 4 mm i.d., 5 µm particle size) (Merck®) was used [35].  This 
method was developed for samples which contain hydroquinone as the only active SLA 
since kojic acid and arbutin can cause interference in both methods [35]. 
Majmudar et al. developed a method for the determination of kojic acid in SLPs 
by using HPLC [20].  The chromatographic conditions consisted of a C8, ODS-5, 150 × 
4.5 mm column and a mobile phase composed of water:acetonitrile (20:80 v/v).  The 
wavelength of detection was 254 nm [20].  This method was developed to evaluate the 
toxicity of SLAs and SLPs before they can be tested on humans [20]. 
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Gagliardi et al. developed a method where a tandem thin-layer HPLC was used 
for the identification and determination of corticosteroids in cosmetic products [36].  
The analytical column used was a 250 mm × 4.6 mm i.d stainless steel column packed 
with 5 µm endcapped Purospher RP-C18 (Merck, Darmstadt, Germany) [36].  Three 
eluting conditions were adopted: (A) isocratic elution with the mobile phase 
acetonitrile-water, in the ratio 60:40 (v/v); (B) gradient elution from acetonitrile –water 
in the ratio 25:75 (v/v) to 90% acetonitrile in 30 min, the final composition was 
maintained for 10 min before re-equilibrating the column; and (C) isocratic elution with 
acetonitrile [36].  The detection wavelength used was 239 nm [36].  There were 51 
corticosteroids which were  analysed [36].  The method has been applied to the analysis 
of 80 cosmetic products marketed within the European Union [36]. 
Reepmeyer et al. reported a method for the determination of clobetasol 
propionate.  Chromatographic separation was obtained by using reversed-phase and 
normal-phase chromatography [37].  The analytical column used for reversed-phase 
chromatography was a Nova-Pak C18 column (150 × 3.9 mm, 4 µm particle size, Waters 
Associates) [37]. The mobile phase was acetonitrile-water (1:1) [37].  The analytical 
column used for normal-phase chromatography was a Chromegasphere SI 60 column 
(250×4.6 mm, 5 µm, E.S. Industries) [37].  The mobile phase was isopropanol-heptane 
(1:4) [37].  The signal was scanned from 200 to 350 nm in order to record the UV 
spectra and the chromatogram were monitored at 240 nm [37]. 
Lin et al. combined HPLC with online microdialysis sampling for the 
simultaneous determination of ascorbyl glucoside, kojic acid and niacinamide in skin-
whitening cosmetics [38].  Separation was achieved on a 5 µm, 250 mm × 4.6 mm i.d. 
Hypersil Fluophase PFP column (Cheshire, England) and the analytes were detected 
through UV absorption at 254 nm [38].  The HPLC eluent was 40% (v/v) methanol in 
0.020 M phosphate buffer [38].  The method was used to analyse six commercial 
cosmetic products.  On-line microdialysis sampling was used because the authors claim 
the method gives a more simple sample pretreatment and a lower degree of sample 
contamination [38].  The method is also less time consuming [38]. 
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1.9 Aim and objectives of this study 
A large number of women have been visiting dermatologists with skin problems.  
A number of products containing skin-lightening agents have been banned by some 
African countries such as Kenya, Gambia and Burkina Faso [28].  Despite these bans, 
products containing hydroquinone, glucocorticoids and mercury soaps are still 
advertised and sold [28]. 
Regulations have been established for cosmetics, product evaluation, chemical 
analyses and safety testing to protect consumers [12].  Regulations require that the 
product ingredients be listed on the product label with the exception of fragrances and 
flavours [12, 33].  Some of the cosmetic products in the South African market list the 
ingredients but most of them do not state the quantity of the SLAs in the creams.  The 
consistency of the contents of the products with those of the ingredients on the label is a 
concern as some of the creams give rise to adverse effects which are not consistent with 
the product label [12]. 
In this project, a method was developed for the analysis of skin-lightening 
agents in skin-lightening creams by using HPLC.  This was achieved with the following 
specific objectives. 
1.9.1 Specific objectives 
 Various standards of SLAs were obtained. 
 The standards were analysed by UV and fluorescence spectrophotometry so as 
to determine their UV absorbance wavelength and their excitation and emission 
wavelengths for florescence. 
 Method development was performed by using the results obtained by UV and 
fluorescence spectrophotometry to detect the analytes of interest in HPLC. 
 Once a suitable method was identified, the SLP samples were analysed to see if 
there was separation of the different components. 
 Optimisation of the extraction time and solvent was evaluated. 




 Calibration plots were obtained for the standards that were qualitatively found to 
be present in the samples. 
 The samples were analysed in triplicate and the data was analysed to obtain the 
concentrations of the SLAs in the SLPs. 
 GC was also attempted in order to verify the results obtained by HPLC. 
 Phenolic compounds were derivatised with BSTFA to make the standards 
volatile. 
 Qualitative analysis of the samples was done by using GC-MS. 
The HPLC method was used to qualitatively identify the skin-lightening agents 
in the samples and thereafter quantify them provided their standards were available. The 
method was used to analyse 35 different skin-lightening creams purchased at the market 
in Durban, KwaZulu-Natal. 
Public education has become important as cosmetics have a number of different 
chemicals in them which may impact negatively on the skin or be banned or restricted.  
This work is necessary so that women can know which skin-lightening creams are good 
for their skins and which ones possess harmful compounds that can be detrimental for 
their skin. 
1.10 Dissertation overview 
The following dissertation is composed of 2 sections. Section A covers the analysis of 
SLA in SLP, and this is from Chapter 1 to Chapter 4.  Section B concerns the analysis 
of clays used by South African women on their faces as a sunscreen.  This can be 
obtained from Chapter 5 to Chapter 8. 
Section A  
Chapter 1 provides an overview of what skin lightening agents are, why people 
use them and how they function on the skin.  It includes regulations and side-effects of 
some commonly used SLAs in the market.  Various methods which have been used in 
the analysis of SLAs are reported.  Different HPLC methods reported by different 
authors are reviewed for the analysis of SLAs.  The specific objectives and aims of the 
study are discussed. 
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Chapter 2 covers the experimental part of the HPLC and GC-MS work carried 
out.  The theory of the instrumentation is covered as well as the experimental 
procedures carried out.  This chapter also includes precautions to be taken when using 
HPLC, and derivatisation of the standards and samples in order to be able to analyse 
them by using GC-MS. 
Chapter 3 presents the results and discussion of the analysis.  It includes 
difficulties experienced during the research.  It discusses the process of the method 
development.  It was found that some of the SLPs contained SLAs which are banned in 
over-the-counter products and some had amounts that exceed the limits allowed in 
South Africa.  The results obtained by GC-MS were not conclusive. 
Chapter 4 is where the conclusion of the first section on the SLAs is drawn. 
Section B 
Chapter 5 gives a detailed overview about clays and their uses.  It defines clays 
and what is required for a material to be called clay.  It also covers the white and red 
clays used by South African women to protect their skin. 
Chapter 6 outlines the experimental method and different principles of the 
instrumentation used. 
Chapter 7 covers the results from the experimental and the discussion.  The 
characteristics of the clays based on the obtained results are discussed. 
Chapter 8 contains the conclusion for section B.  However, it was noted that 
further studies should be done to assess the toxicity of the clays as this is not currently 
known. 
The references are listed after Chapter 8 and Appendices A to E provide details of 
the chemicals used, the UV and fluorescence spectra of the standards as well as the 






This chapter describes the materials, equipment and methods used to identify skin-
lightening agents in commercially available skin lightening creams and also their 
quantitative analysis. 
2.1 Materials 
The chemicals used are listed in Appendix A including their chemical grades and 
manufacturers information.  All the reagents used were of analytical or HPLC reagent 
grade.  Methanol, 2-propanol and THF were all HPLC grade solvents.  Pyridine was 
analytical grade.  Water was purified by a Millipore Milli-Q system. 
The skin-lightening products were provided by Dr N Dlova of the University of 
KwaZulu-Natal Medical School.  They were stored at room temperature in a dark 
cupboard before extraction.  The extracted samples were stored in the refrigerator prior 
to the analysis.  A list of all samples analysed can be found in Table 2.1 with product 
information and names of the manufactures. 
2.2 Ultraviolet and visible (UV/vis) spectrophotometry 
A number of skin-lightening agents have been analysed by means of HPLC, with 
a UV detector.  This requires knowledge of the wavelength of maximum absorption for 
each of the possible analytes.  By using these different wavelengths that the compounds 
absorb, one can differentiate them based on their UV spectrum and retention times with 
HPLC.  The HPLC used in this project had a photodiode array (PDA) detector which 
made it possible to obtain the UV spectrum of each individual peak in the 





Table 2.1  Details of the commercial skin-lightening products investigated in this study. 
Product 
Label 
Brand name Country of 
manufacture 
Company Active ingredients 
declared on product 
label 
Side effects or warnings 
given on packaging label 
1 BCO original skin repair 
cream 
South Africa Champion 
Cosmetics 
- - 
2 Gentle magic lotion - - - - 
3 Unknown - - - - 
4 Beta cream South Africa Mthatha plaza & 
Triangle 
Pharmacies 
- Avoid sunlight exposure 
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5 Pure perfect parfait (6) South Africa Pure perfect cc Kojic acid dipalmitate 
Arbutin 
Apply broad spectrum 
sunscreen of at least SPF 
15 while using product and 
a week after discontinued 
use. 
6 Pure perfect parfait (7) South Africa Pure perfect Kojic acid dipalmitate 
Arbutin 
Apply broad spectrum 
sunscreen of at least SPF 
15 while using product and 
a week after discontinued 
use. 
7 Pure perfect parfait (8) South Africa Pure perfect Kojic acid - 
8 Pure perfect parfait (24) South Africa Pure perfect Kojic acid dipalmitate 
Arbutin 
Apply broad spectrum 
sunscreen of at least SPF 
15 while using product and 




9 Pure perfect parfait (25) South Africa Pure perfect Kojic acid dipalmitate 
Arbutin 
Apply broad spectrum 
sunscreen of at least SPF 
15 while using product and 
a week after discontinued 
use. 
10 Quick and clear blemish 
cream 
South Africa - - Avoid excessive exposure 
to sunlight while using the 
product. 
11 Bioclear vanishing cream South Africa - - If no adverse effects occur 
continue to apply as 
directed. 
12 Bioclear nourishing cream South Africa - - If no adverse effects occur 
continue to apply as 
directed. 
13 Hypercreme plus Beauty 
toning cream 
Switzerland Hypercreme - Avoid contact with eyes. 




14 Skin spor G.S South Africa Mthatha Pharmacy - - 
15 Fair and white whitening 
cream 
France Labo Derma - - 
16 Dabur Uveda complete 
fairness cream 
India Dabur India Ltd - - 
17 Fem bleach cream India Fem Care Pharma 
Ltd 
Hydrogen peroxide - 
18 Fem post bleach India Fem Care Pharma 
Ltd 
- - 
19 Fem pre-bleach India Fem Care Pharma 
Ltd 
Hydrogen peroxide - 
20 Magic amabala lotion - - - - 
21 Hypoderm day cream South Africa Cosmetic 
Warehouse, Epping 
Vitamin C derivate - 
25 
 
22 Hypoderm night cream South Africa Cosmetic 
Warehouse, Epping 
- - 
23 Hypoderm cream with 
moisturiser 
South Africa Cosmetic 
warehouse, Epping 
- - 
24 Caro light Democratic 
Republic of the 
Congo 
Angel Cosmetics 2% Hydroquinone - 
25 Eraser antimarks cream India IPSA labs (p) Ltd. - Discontinue use if irritation 
occurs. 
26 Ponds perfect colour 
complex beauty cream 
normal to oily skin 
India Ponds Institute Niacinamide Apply a broad spectrum 
sunscreen of at least SPF 
15 while using and after a 
week of discontinued use 
of the product. 
27 Fair and radiant India Fem Care Pharma 
Ltd 
- Apply the cream half an 
hour before going into the 




28 Paw paw fortuneapple 




Fortuneapple Arbutin - 
29 Paw paw fortuneapple 




Fortuneapple Arbutin - 
30 Paw paw fortuneapple 
freckle remover day cream 
People’s Republic 
of China 
Fortuneapple Arbutin - 
31 Gold aloe whiten 
moisturizing-cream 





cosmetics Co., Ltd 
- Do not apply to healthy 
skin. 
Special skin produces 
swollen suppuration. 
32 La Belle beauty masks 
(mask cloth) 
China La Belle Anti-melanin element 
extract 
Do not use if allergic to any 
of the ingredients. 
Avoid contact with eyes. 




33 La Belle beauty masks (gel 
in mask) 
China La Belle Anti-melanin element 
extract 
Do not use if allergic to any 
of the ingredients. 
Avoid contact with eyes. 
Do not apply to broken or 
inflamed skin. 
34 Diproson India Shalina Betamethasone 
dipropionate 
Systemic absorption of 
diproson has produced 
reversible hypothalamic-
pituitary-adrenal (HPA) 
axis suppression.  If it is 
noted withdraw from the 
cream, or reduce frequency 
of application. 





2.2.1 Theory and instrumentation 
Ultraviolet and visible (UV/vis) spectroscopy provides information about 
compounds based on their ability to absorb radiation in the UV/vis region.  Ultraviolet 
and visible light have enough energy to promote an electron from one molecular orbital 
to another of a higher energy, this is known as an electronic transition [39].  The energy 
needed for the electronic transition will determine whether the compound absorbs either 
ultraviolet or visible light.  A UV spectrum is obtained if a compound absorbs UV light 
and a visible spectrum is obtained if a compound absorbs visible light. Compounds that 
absorb visible light are coloured, whereas those that absorb UV light do not need to be 
coloured.  Ultraviolet light has wavelengths ranging from 180 to 400 nm whereas 
visible light has wavelengths ranging from 400 – 780 nm. 
The wavelength at which an organic compound absorbs depends on how tightly its 
atoms in a molecule are held, but the wavelength is inversely proportional to the energy 




where E is the energy, h is plank’s constant, c is the speed of light and λ is the 
wavelength of absorption. 
Carbon-carbon bonds or carbon-hydrogen bonds have shared electrons in single 
bonds that are tightly held such that their excitation requires energies corresponding to 
wavelengths below 180 nm, which is known as the vacuum UV region [40]. 
The compounds of interest were organic compounds and were not coloured.  
This made the compounds to be inactive in the visible region of the spectrum.  Electrons 
in double and triple bonds are not so tightly held compared to single bonds, and 
therefore can be more easily excited by radiation.  Ultraviolet light has only enough 
energy to cause electronic transitions from a nonbonding (lone pair) electron (n) into an 
π* antibonding molecular orbital, and also the electronic transition from a π bonding 
molecular orbital into a π* anti-bonding molecular orbital [39].  Thus, only organic 
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compounds with π bonding electrons can produce UV spectra because both transitions 
promote electrons into a π* anti bonding molecular orbital. 
 The UV spectra were measured by means of a double-beam Perkin Elmer 
Lambda 35 UV/vis spectrophotometer.  The light from the source which is usually a 
deuterium lamp for UV and a tungsten lamp for the visible region passes through a 
monochromator, which filters the light to a narrow wavelength.  The filtered radiation 
then splits into two light beams, where one passes through the blank (solvent) and the 
other passes through the sample.  The output from the detector is the absorbance of the 
sample having accounted for that of the solvent from the reference cell. 
 According to Beer’s law, absorbance (A) is directly proportional to the 
concentration (c) of the absorbing sample and the optical pathlength (b) through which 
the sample absorbs the light.  The proportional constant is referred to as the absorptivity 
(ε) in cm-1 mol-1 × dm3. 
=  
The concentration of the samples must be low in order for Beer’s law to be 
obeyed [40].  The absorbance of the standard mixtures was kept below a value of 1.5. 
2.2.2 Preparation of standards and analysis 
Standard solutions were prepared by weighing pure samples of known skin-
lightening agents and dissolving in methanol to make solutions of ~1×10-3 mol L-1 in 
50.00 mL volumetric flasks.  The standard solutions were then diluted qualitatively to 
give UV absorption of not more than 1.5.  A scan of the standards between the 
wavelengths of 200 - 500 nm was obtained.  Quartz cuvettes with a pathlength of 1 cm 
were used for the analysis.  The wavelength of maximum absorbance for all standards 
were noted and used in HPLC analysis. 
2.3 Fluorescence spectroscopy 
This is a photoluminescence process in which molecules are excited by absorption 
of electromagnetic radiation [40].  The excited species relax to the ground state, and 
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give up their excess energy as a photon; this takes a few nanoseconds.  This technique 
has a higher sensitivity compared with absorbance spectroscopy. 
Fluorescence is just one of the pathways a molecule can take to return to the 
ground state.  All compounds have the potential to fluoresce, but some structures 
provide radiationless pathways for relaxation which occur at a faster rate than 
fluorescence, hence they do not fluoresce [40].  Aromatic rings in compounds give the 
most intense molecular fluorescence emission [40].  Certain highly conjugated double 
bonded structures, and aliphatic and alicyclic carbonyls, have the ability to fluoresce 
[40].  Fluorescence is measured by first exciting the sample at the absorption 
wavelength, and then measuring the emission which usually happens at longer 
wavelengths than absorption.  In order to prevent self-absorption and the inner filter 
effect the concentration of the solutions used to measure fluorescence spectra should 
have concentrations such that their absorbance is less than 0.05 at the excitation 
wavelength. 
Standard solutions were prepared as described in Section 2.2.2.  To obtain the 
fluorescence spectra, very dilute samples had to be used since fluorescence has higher 
sensitivity.  The standards were qualitatively diluted to give the best spectra. 
The cuvettes used were quartz and the instrument was a Perkin Elmer LS50B 
luminescence spectrometer.  The standards were excited at the wavelengths according to 
Table 2.2 and their spectra obtained. 
Table 2.2  Excitation wavelengths used for the determination of fluorescence spectra of 


















fluocinolone acetonide 225 
4-phenoxyphenol 218 
clobetasol propionate 220 
 
The values obtained where used in the fluorescence detector of the HPLC in order 
to determine the presence of SLAs in SLPs. 
2.4 High performance liquid chromatography 
HPLC was used for the analysis of the samples. This method is one of the most 
widely used for the analysis of skin-lightening agents. 
2.4.1 Theory and instrumentation 
HPLC is an elution chromatography that separates compounds based on their 
polarity.  It requires a mobile phase, stationary phase, pump and detector.  The 
stationary phase is in a column with a small diameter and the particle sizes are very 
small.  There are different kinds of stationary phases which allow for different kinds of 
chromatography based on the separation mechanism. 
The mobile phase is also an important component of HPLC.  The mobile phase 
must be compatible with the stationary phase since it must not damage or dissolve it.  It 
must also be able to dissolve the analyte of choice, since precipitation of the analyte in 
the column can lead to damage.  
For the mobile phase to be able to pass through the small column, pressure needs 
to be applied.  This allows for fast separation compared to normal liquid 
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chromatography.  There are two types of elutions: isocratic and gradient elution.  
Isocratic elution is when the composition of the mobile phase stays constant with time, 
whereas for gradient elution the mobile phase changes with time.  
A detector is needed for the analysis of the compounds in the analyte.  To 
minimize extra column band-broadening the detector must have a low dead volume.  
UV/Vis detectors are the widely used in HPLC systems, although these are not the only 
detectors that can be coupled with HPLC.  Other detectors that can be coupled with 
HPLC include the PDA, mass spectrometers, fluorescence, etc. 
In this project a column with a reversed phase packing was used.  This is called 
a C18 column, because its stationary phase is composed of silica bonded with octyldecyl 
groups.  By introducing the long carbon chain, the polarity of the silicon (normal phase) 
is changed and we obtain a nonpolar stationary phase.  The mobile phase used is 
normally relatively polar such as water, methanol and acetonitrile.  These are the most 
used mobile phases in reversed phase chromatography.  The most polar compounds are 
eluted first and increasing the polarity of the mobile phase decreases the elution time 
[40]. 
Two instruments were used for the analysis of SLAs.  The first HPLC 
instrument used for this research was a Shimadzu which consisted of: Prominence auto-
sampler (SIL-20A), Prominence degasser (DGU-20A5), Prominence liquid 
chromatograph (LC-20AT), Prominence diode array detector (SPD-M20A) and a 
fluorescence detector (RF-10AXL).  The instrument had to be changed due to the 
instrument becoming contaminated and several clean-up methods could not sufficiently 
clean the instrument.  This instrument was used for the method developments described 
in Section 2.4.5. 
The second HPLC instrument was a Shimadzu-UFLCXR which consisted of a 
Prominence auto sampler (SIL-20AXR), Prominence degasser (DGU-20A3), 
Prominence liquid chromatograph (LC-20ADXRX2), Prominence diode array detector 
(SPD-M20A), Prominence column oven (CTO-20A) and a Prominence communications 
bus module (CBM).  This instrument was used for the qualitative analysis of standards, 
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recovery analysis, intra-day and inter-day analysis, and for the quantification of the 
SLAs in the creams. 
2.4.2 Precautions while using HPLC 
The use of HPLC requires the use of HPLC grade solvents.  These solvents 
contain HPLC-grade on their labels.  The water used must be Millipore water with a 
resistance below 18 Ω.  The solvents always have to be filtered through a 0.45 µm 
filtering system to insure there are no contaminants.  The HPLC used in this project 
contained a degasser.  The mobile phase must be purged with helium gas in cases were 
the instrument does not have a built-in degasser.  Air bubbles interfere with the analysis 
and can increase the pressure of the pumps.  One must ensure that the pressure of the 
pumps does not exceed the maximum pressure allowed for the instrument.  Most 
instruments these days are equipped with a built-in warning which switches off the 
pump if the pressure limit is exceeded. 
When using acidic or basic mobile phases one must make sure the column used 
is compatible with such pHs, for example, at very low pHs the C18 column loses its 
stationary phase.  It is essential that no carryovers from the previous runs are obtained.  
This can be checked for by running blanks in between each run.  In instruments with 
automatic rinses, one must make sure the rinsing solvent bottle always has sufficient 
solvent and that the instrument is rinsing the injector. 
2.4.3 Column performance test 
A column performance test was done to check if the instrument was functioning 
well and also the state of the column.  The column used was brand new, which was a 
Perkin Elmer Brownlee Pecosphere C18 (150 ×4.6 mm I.D., 5 µm) column.  The column 
did not come with a certificate of analysis chromatogram.  A test mixture was obtained 
from the manufacturer which was made up of uracil, naphthalene, acetophenone, 
toluene and benzene.  The mixture was an already made mix. It was made in 75% 
methanol and 25% acetonitrile.  The concentration of the mixture was stated as 1 mg L-
1.  The column performance test was done by using 60% methanol with 40% water as 
the mobile phase.  The flow rate was set at 1 mL min-1, the injection volume was 5 µL, 
the detection wavelength was 210 nm and the run time was set at 30 minutes. 
34 
 
The chromatogram obtained was compared with the chromatogram which came 
with the test mix.  The results of the column performance test are discussed in Section 
3.2. 
2.4.4 Standards and sample preparation 
Standard solutions were prepared by dissolving a specific mass of pure skin 
lightening agents in methanol to give a concentration of ~1 × 10-3 mol L-1.  A total of 35 
standards were prepared and analysed. 
Samples were prepared by weighing ~0.05 g of skin-lightening cream into a 
beaker, adding 4 ml of methanol and sonication for 15 minutes in an ultrasonic bath.  
The samples were quantitatively transferred into a 10.00 mL volumetric flask and made 
to the mark by using methanol.  All samples were filtered through a 0.45 µm disc 
syringe filter directly into HPLC 1.5 mL vials before analysis. 
2.4.5 Method development 
Sixteen standard solutions prepared according to the method in Section 2.4.4 
where used for method development.  The standards used were hydroquinone, 
resorcinol, p-benzoquinone, N-acetyl-L-cysteine, p-arbutin, kojic acid, phenol, 4-
hydroxyanisole, dexamethasone, 4-propoxyphenol, hydrocortisone, hydrochinon-
dimethylether, 6α-methylprednisolone, fluocinolone acetonide, 4-phenoxyphenol and 
clobetasol propionate. 
The standards were analysed individually and as a mixture, by using different 
solvents systems.  Isocratic and gradient elutions were investigated.  Although not all 
standards had base line resolution, the mobile phase composition was narrowed down to 
60% methanol in water (v/v) and 50 % methanol in water (v/v), isocratic elution.  The 
mobile phase was prepared manually and the filtered through a 0.45 µm filtering 
system.  The water used was Millipore water from a Millipore Milli-Q water 
purification system with conductivity of less than 18.2 Ω cm-1 at 25 ºC while the 
methanol was HPLC-grade. 
An analytical column Brownlee Pecosphere C18 (150 × 4.6 mm I.D., 5 µm) 
column was used for the method development.  The flow rate of all runs was maintained 
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at 1 mL min-1 and the injection volume used was 10 µL.  The results were collected at 
three wavelengths 240, 270 and 289 nm, which were determined to be appropriate for 
all standards in Section 2.2.2. 
Prepared samples were then analysed by using the two best mobile phase 
compositions.  Based on the separation of the components in the SLCs samples, it was 
found that the 50% methanol in water mobile phase gave the better separation compared 
with 60% methanol in water. 
2.4.6 Qualitative analysis of samples 
A total of 35 samples (Table 2.1) were analysed by using the parameters given 
in Section 2.4.5.  The results obtained were compared with the chromatograms of the 
individual standards, by comparing the retention times and UV spectra from the PDA.  
Spiking of some samples was done to positively identify the peaks. 
2.4.7 Determination of optimum extraction method for samples 
The extraction of the skin-lightening agents (SLA) in the creams is also an 
important factor in their analysis.  The extraction method must be able to extract the 
maximum amount of the SLA in the creams. 
Two different parameters were investigated: the extraction solvent and the 
extraction time.  Three different solvents were used, namely, methanol, 2-propanol and 
50% methanol in water (v/v). Two samples were analysed to test the parameters.  
The samples were prepared according to the method described in Section 2.4.4, 
replacing methanol with the appropriate extraction solvent.  All samples were extracted 
for 15 and 30 minutes to investigate the best extraction time. 
The column used for this analysis was a Brownlee C18 (100 × 4.6 mm I.D., 3 µm 
particle size) analytical column.  The column was changed from the Brownlee 
Pecosphere C18 (150 × 4.6 mm I.D., 5 µm) due to peak-tailing experienced.  The 
Brownlee C18 (100 × 4.6 mm I.D., 3 µm particle size) analytical column was used for 
the quantification of the skin lightening agents.  
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The best extraction solvent was found to be 2-propanol for an extraction time of 
15 minutes. 
2.4.8 Quantitative analysis of samples 
An external calibration curve method was used to quantify the SLA identified 
from the qualitative analysis of the SLCs.  It was found that phenol, hydroquinone, p-
arbutin and benzoquinone could be identified based on their retention times and UV 
spectra. 
Multi-standard stock solutions were accurately prepared by weighing 
approximately, phenol (0.0030 g), arbutin (0.0120 g) and dexamethasone (0.0040) into 
a 10.00 mL volumetric flask to give a concentration of approximately 300, 1200 and 
1400 mg L-1 respectively.  The standards were grouped such that there is no co-elution 
in HPLC.  Phenol, arbutin and dexamethasone were grouped together whereas 
benzoquinone, niacinamide and hydroquinone were prepared separately. A mass of 
niacinamide (0.0080 g) was accurately weighed into a 10.00 mL volumetric flask to 
give a concentration of 800 mg L-1.  A mass of benzoquinone (0.0125 g) was weighed 
in a 25.00 mL volumetric flask to give an approximate concentration of 500 mg L-1.  A 
mass of hydroquinone (0.0090 g) was weighed in a 10.00 mL volumetric flask to make 
a solution of approximately 900 mg L-1.  The stock solutions and methanol were filtered 
through a 0.45 µm disc filter. 
Working from the stock solutions, volumes of 4 µL, 15 µL, 25 µL, 45 µL, 70 
µL, 85 µL and 100 µL were measured into individual HPLC vials.  To each vial 
methanol was added to make the final volume of the standards 1000 µL by taking 996 
µL, 985 µL, 975 µL, 955 µL, 930 µL, 915 µL and 900 µL respectively into the HPLC 
vial.  In some cases instead of using 4 µL of the standard solutions, 10 µL was used and 
then 990 µL of methanol was added to that HPLC vial.  Dilution of the standards was 
done with a Perkin Elmer series 200 auto-sampler. 
A mass (0.05 g) of each of the samples was weighed into a beaker in which a 
volume (4 mL) of methanol was added.  The mixture was then sonicated in an ultra-
sonic bath for 15 minutes.  The supernatant was transferred into a 10.00 mL volumetric 
flask being careful not to take the solid which did not dissolve in the solvent.  The 
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samples were made to the mark with methanol.  A small aliquot was filtered through a 
0.45 µm syringe filtering disc into a HPLC vial and then analysed. 
2.4.9 Recovery 
Recoveries were performed to determine the accuracy of the developed method.  
This was done by spiking samples with the SLA standards.  The samples spiked were 
those which were determined not to have any peaks close to those of the standard to be 
added.  Recovery was done for hydroquinone (0.0015, 0.0045 and 0.0080 g in a 100 mL 
volumetric flask), niacinamide (0.0006, 0.0016 and 0.0035 g in a 50 mL volumetric 
flask), arbutin (0.0006, 0.0030 and 0.0050 g in a 50 mL volumetric flask), phenol 
(0.0006, 0.0015 and 0.0025 g in a 100 mL volumetric flask) and dexamethasone 
(0.0006, 0.0017 and 0.0024 g in a 100 mL volumetric flask) 
High, medium and low masses of the standards were weighed directly into a pre-
weighed sample of the cosmetic cream.  The samples were then treated as described in 
Section 2.4.8.  All samples were prepared in triplicate.  The mass of SLA weighed into 
the sample was different for each SLA.  
2.4.10 Inter-day and Intra-day analysis 
Inter-day (over a period of 3 days) and intra-day (same day) analysis was done to 
determine the accuracy and precision of the instrument.  The reproducibility of the 
results was done by using standards.  The standards were prepared as described in 
Section 2.4.8.  The HPLC method described in Section 2.4.8 was used to analyse the 
standards. 
Intra-day analysis was done by running the standards 3 times over a period of 1 
day.  Each standard was injected 3 times.  Inter-day analysis was done by analysing the 
standard every day for a period of 3 days.  This was done to determine the accuracy of 
the HPLC method developed.  The results are reported and discussed in Section 3.6 
2.5 Gas chromatography-mass spectroscopy 
Gas chromatography coupled to a mass spectrometer (GC-MS) is a good method 
to identify compounds which are unknown.  Consequently, GC-MS was attempted in 
this work in order to identify unknown compounds in the SLP samples. 
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2.5.1 Theory and instrumentation 
Gas chromatography (GC) separates compounds based on their boiling points.  
The sample is vaporised and then partitioned between a gas and a stationary phase.  The 
mobile phase in this case is a gas, which does not interact with the analyte, but just 
transports it through the column and since the carrier gas does not interact with the 
analyte, it must be chemically inert.  Some of the gases used in GC are hydrogen, 
helium, argon and nitrogen.  Just like with HPLC, GC also has different columns which 
determine the kind of separation obtained. 
The sample is injected into an injector port which is set at a certain temperature, 
usually higher than the boiling point of the analyte of interest.  The injection of the 
sample is important since reproducibility is of interest.  The sample injected must not be 
too large as this could result in overloading of the column.  Injection must be fast; slow 
injections cause band-broadening which is undesirable. 
Temperature programming is important as it affects the separation of the 
compounds.  For samples with a broad boiling range, temperature programmes can be 
used.  This involves increasing the column temperature in steps or continuously during 
elution [40]. 
Mass spectrometry is used as a detector in GC.  The combination of GC and MS 
is called GC-MS.  The mass spectrometer measures the mass to charge ratio of the 
analyte that has been fragmented.  Different compounds have different fragmentation 
patterns, which allows for the compounds to be identified based on the pattern.  This has 
allowed for libraries with GC-MS data of different compounds to be developed.  In a 
GC-MS system, the analyte which has been separated by the GC enter the mass 
detector.  In the mass spectrometer, the molecules enter the ionisation source, which 
ionises the sample.  This source is powerful enough to break the chemical bonds of the 
molecules, but they do not decompose it.  This is how fragments of the molecules are 
obtained.  The fragments then enter an analyser where a current is employed, such that 
the uncharged molecules will be discarded and only the charged fragments will pass 
through to the ion detector. 
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The GC-MS allows for the mass spectrum of each peak on the chromatogram 
from the GC to be obtained and identified.  The instrumentation used was a Agilent 
6890 (Palo Alto, CA, USA) gas chromatograph (GC), coupled to a 5973N series mass 
spectrometer (MS) operated in electron impact (EI) ionization mode.  The column was a 
DB5 which was 30 meters in length. 
2.5.2 Preparation of standards and samples 
The standards used for qualitative analysis were composed of mostly phenolic 
compounds, which are not sufficiently volatile for GC-MS analysis.  Standards and 
samples had to be derivatised before they could be analysed.  The derivatisation agent to 
be used was N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA). 
The temperature programme was set as, 50 °C held for 2 minutes, then an 
increase of 20 °C min-1 to 295 °C then held there for 10 minutes.  The split ratio was set 
at 1:50. The injection volume used was 1 µL.  Standards were prepared directly into a 
GC vial to make a multi-standard, hydroquinone (0.0022 g), resorcinol (0.0047 g), 
arbutin (0.0017 g) and kojic acid (0.0010 g). Pyridine (100 µL) was added followed by 
BSTFA (100 µL).  The sample vial was closed and heated in an oil bath at a 
temperature of about 65-70 °C for 30 minutes.  The standard was allowed to cool before 
analysis.  The same standards were analysed separately to identify the individual 
components in the chromatogram of the mixture and to obtain the individual mass 
spectra. 
Qualitative analysis of all standards that had an –OH group which could be 
derivatised where analysed.  The following standards where analysed: hydroquinone (18 
µg mL-1), kojic acid (13 µg mL-1), resorcinol (24 µg mL-1), phenol (194 µg mL-1), 4-
propoxyphenol (25 µg mL-1), 4-phenoxyphenol (18 µg mL-1) and 4-hydroxyanisole (13 
µg mL-1).  Some of the steroids were also prepared, but the column oven could not be 
heated high enough to enable their analysis. 
Samples were prepared by weighing 0.5 g into a beaker; 5 mL of pyridine was 
added.  The mixture was ultrasonicated for 30 minutes, transferred quantitatively to a 
10.00 mL volumetric flask and then made up to the mark with pyridine.  A small 
volume was filtered through a 0.45 µm syringe filtering disc.  A volume of 200 µL of 
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the filtered sample was then added into a sample vial, and 250 µL of BSTFA was 
added.  The samples were derivatised by using the same procedure as described above.  
Liquid samples which could not be weighed were prepared by adding 100 µL of the 
sample into the vial in which 100 µL pyridine was added to dilute the samples.  The 
volume of the derivatisation agent added was the same as for solid samples, i.e. 250 µL.  
The samples where then derivatised and analysed by using GC-MS. 






3 Results and discussion 
Skin-lightening creams have been in the market for many years and there 
continues to be research into finding new SLAs that do not harm the skin.  Restrictions 
have been imposed on the use of hydroquinone since occurrences of side-effects 
associated with its use were reported.  South Africa was the first country to limit the use 
of hydroquinone in over-the-counter products to 2% (m/m), and later other countries 
followed suit [9].  Other SLAs have been developed as researchers try to find a suitable 
agent that can replace hydroquinone.  Today there are many SLAs and some of these are 
detrimental to the skin.  There have been reports of SLPs having side-effects that 
correspond to the use of steroids.  Some products falsely list their ingredients, while 
some vendors sell products containing banned SLAs.  It is therefore important that the 
SLAs in SLPs be known.  There need to be strong laws that prohibit the sale of illegal 
SLAs.  It is also important that the public knows what they are putting on their skin and 
the consequences of their actions in terms of side-effects. 
This research develops two methods to qualitatively and quantitatively determine 
SLAs in SLPs.  These experiments are detailed in Chapter 2.  Levels of hydroquinone, 
phenol, niacinamide and arbutin were qualitatively and quantitatively identified in a 
number of skin-lightening products which are readily accessible without the use of a 
prescription.  The investigation was done with the use of HPLC equipped with a PDA 
and a fluorescence detector. GC-MS was also used to qualitatively identify the SLAs in 
the creams. 
3.1 Optimum detection wavelengths 
The UV-visible spectra of different SLA standards were measured by dissolving 
the standards in methanol.  The wavelength of maximum absorption of distinguishable 
peaks were observed and recorded (see Table 3.1). Most compounds have high 
absorptions at low wavelengths, making them indistinguishable.  By using the 
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wavelength of the peak with the second highest absorbance allowed for the compounds 
to have different wavelengths for analysis, even though they were not the maximum 
wavelengths.  This was important since selectivity was needed and the compounds were 
sensitive at the other wavelengths as well.  Therefore, selectivity and sensitivity was 
achieved this way. 
Table 3.1  UV/vis absorbance and fluorescence emission wavelengths of SLA standards 






hydroquinone 293 329.18 
resorcinol 276 308.44 
p-benzoquinone 243 329.52 
N-acetyl-L-cysteine 200 - 
p-arbutin 286 321.06 
kojic acid 269 - 
phenol 272 299.96 
4-hydroxyanisole 291 322.87 
dexamethasone 239 458.08 
4-propoxyphenol 292 324.85 
hydrocortisone 241 458.57 
hydrochinon-dimethylether 289 318.52 
6α-methylprednisolone 243 458.57 
fluocinolone acetonide 237 - 
4-phenoxyphenol 227 323.61 
clobetasol propionate 238 - 
 
Thus, for HPLC the PDA detector was set to acquire chromatograms at three 
wavelengths to cover the wavelengths in Table 3.1, namely, at 240, 270 and 289 nm.  
The fluorescence detector was set at an excitation wavelength of 280 nm and an 
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emission wavelength of 320 nm.  These wavelengths were chosen such that they could 
cover all the compounds that fluoresce based on the results in Table 3.1.  The 
wavelengths used for each analyte for the PDA detector are listed in Table 3.2.  
Although some of the SLAs had maximum wavelengths of 200 nm, this value could not 
be used as many other analytes as well as solvents absorb at this wavelength.  The 
wavelengths chosen allowed for sensitivity at a specific wavelength. 
















fluocinolone acetonide 240 
4-phenoxyphenol 240 
clobetasol propionate 240 
fluticasone propionate 240 
mometasone furoate 240 
triamcinolone acetonide 240 
beclomethasone dipropionate 240 
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nicotinamide (niacinamide) 240 
betamethasone 17-valerate 240 
betamethasone 17,21-dipropionate 240 
 
3.2 Column performance test 
A column performance test was done according to the method described in 
Section 2.4.3.  The results will be discussed here.  The column performance mixture 
was run and the chromatogram was obtained.  The chromatogram obtained was 
compared with that of the chromatogram that came with the mixture (Figure 3.1). 
The mixture was labelled as having 5 components (1 mg L-1 of uracil, 
naphthalene, acetophenone, toluene and benzene in 75% methanol in 25% acetonitrile), 
but the chromatogram displayed 4 peaks.  This was also what was observed when the 
mixture was analysed (Figure 3.2).  The results from the column displayed a very small 
peak which was not on the test mix chromatogram.  This was acceptable since the 
mixture was supposed to have 5 components.  It was assumed based on the results that 
the column and the instrument were working well since the separation of the peaks was 




Figure 3.1  Reference chromatogram for the mixture used to test column performance of a 
Perkin Elmer Brownlee analytical column, Pecosphere C18 (150 × 4.6 mm, ID) with a 5 µm 
particle size, injection volume 5 µL, mobile phase methanol:water (60:40, v/v), flow rate of 1.0 




Figure 3.2  Chromatogram of column performance of the Perkin Elmer Brownlee analytical 
column, Pecosphere C18 (150 × 4.6 mm, ID.) with a 5 µm particle size, injection volume 5 µL, 
mobile phase methanol:water (60:40, v/v), flow rate of 1.0 mL min-1 and the detection 
wavelength of 210 nm.  
3.3 Optimum HPLC mobile phase 
Once the detector wavelengths had been determined, the mobile phase now 
needed to be optimised.  The column used for the optimisation of the method was a new 
Perkin Elmer Brownlee analytical column, Pecosphere C18 (150 × 4.6 mm, ID.) with a 5 
µm particle size.  
The SLAs in Table 2.2 were used for the optimisation.  The standards were 
analysed individually to obtain the retention times, and then mixed to prepare a 
multicomponent solution that was used to test adequate separation of the compounds.  
Gagliardi et al.  reported a method where isocratic separation of corticosteroids was 
obtained by using acetonitrile-water 60:40 (v/v) as a mobile phase [36].  This was 
chosen as a starting point, but methanol was used instead of acetonitrile because it is 
cheaper.  The multicomponent standard was composed of 13 standards chosen based on 
the retention times.  The standards mixed were hydroquinone, resorcinol, benzoquinone, 
kojic acid, phenol, 4-hydroxyanisole, dexamethasone, 4-propoxyphenol, 
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hydrocortisone, 6α-methylprednisolone, fluocinolone acetonide, 4-phenoxyphenol and 
clobetasol propionate.  The results were obtained by using the PDA and the 
fluorescence detector. 
It was observed that there was no baseline resolution between some of the 
compounds with the aforementioned mobile phase (Figure 3.3) thus different mobile 
phases were investigated (Figure 3.4).  Both isocratic and gradient elution were 
investigated.  It was found that from all the mobile phase combinations attempted, 50% 
methanol in water and 60% methanol in water gave reasonable separation of the SLA.  
Since not all of the SLAs in Table 3.2 are simultaneously obtained in SLCs, samples 
had to be analysed to determine which mobile phase gave the best separation of the 
SLCs. 
By using SLC samples, it was observed that 50% methanol in water (v/v) gave the 
best results, and this mobile phase was chosen as the mobile phase for the analysis of 
SLAs in SLCs.  This mobile phase was then used to obtain the retention times of 
different steroid standards. 
Once the optimum mobile phase was selected, samples were analysed to 
qualitatively identify which SLAs were present in the creams.   This was done by 
comparing the retention times and UV spectra from the PDA, and confirmation which 
was obtained by spiking the sample.  A chromatogram of a sample containing arbutin 
and spiked can be observed in Figure 3.5.  It was found that phenol, arbutin, 
niacinamide, hydroquinone and benzoquinone were the only SLA that could be 
identified.  None of the steroids standards tested were identified in the samples. 
3.4 Linearity and limit of detection 
An external standard calibration method was used to obtain calibration curves for 
the SLAs identified in the creams.  It was assumed that when the same analyte 
concentration is present in the sample then the same response would be obtained with 
the standards.  The standards where prepared in different sets. One multi-standard was 
prepared with a composition of arbutin, phenol and dexamethasone.  The standards that 
were grouped together had different retention times and different detection wavelengths 




Figure 3.3  Separation of 13 SLAs mixture with detection at 240, 270 and 289 nm.  The 
chromatographic conditions used were: Brownlee C18 (150 × 4.6 mm I.D., 5 µm particle size) 





Figure 3.4  Chromatogram of HPLC-fluorescence with a mobile phase of A) 50% methanol in 
water and B) 70% methanol in water giving peaks of a) hydroquinone, b) resorcinol c) 
benzoquinone d) 4-hydroxyanisole, e) phenol, f) 4-propoxyphenol g) 4- phenoxyphenol.  The 
chromatographic conditions used were: Brownlee C18 (150 × 4.6mm I.D., 5 µm particle size) 
column, injection volume 10 µL, flow rate of 1.0 mL min-1 and excitation wavelength used for 




Figure 3.5  HPLC chromatogram of sample 6 confirming the presence of arbutin by spiking.  
The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm I.D., 3 µm particle 
size) column, injection volume 10 µL, mobile phase methanol:water (50:50, v/v), flow rate of 




Table 3.3  Retention times for standards used to obtain calibration data with HPLC and their 
detection wavelengths. 
 Retention time/minutes Detection wavelength/nm 
Arbutin 1.021- 1.049 289 
Niacinamide 1.119- 1.139 240 
Hydroquinone 1.158- 1.171 289 
Benzoquinone 1.384- 1.392 240 
Phenol 1.998- 2.190 270 
Dexamethasone 6.690- 9.884 240 
 
Figure 3.6 displays dexamethasone at its highest peak intensity when detected at 
240 nm.  This is the wavelength that was used for dexamethasone analysis.  Although 
other peaks could be seen at this detection wavelength, they were not quantified at this 
wavelength. 
Phenol has a higher absorbance at 270 nm (Figure 3.7), as can be seen by the 
increase of the peak in comparison to that in Figure 3.6.  Consequently, phenol was 
quantified at this wavelength. 
At a detection wavelength of 289 nm phenol and dexamethasone hardly absorb 
(Figure 3.8) and therefore their peaks are barely visible but arbutin is at its maximum 
absorbance at this wavelength and was quantified at 289 nm. 
Hydroquinone, benzoquinone and niacinamide were prepared separately on their 
own because their retention times were too close to each other and there was no clear 






Figure 3.6  Chromatogram of arbutin, phenol and dexamethasone obtained at a detection 
wavelength of 240 nm. The chromatographic conditions used were: Brownlee C18 (100 × 4.6 
mm I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water 
(50:50, v/v), flow rate of 1.0 mL min-1. 
 
Figure 3.7  Chromatogram of arbutin, phenol and dexamethasone obtained at a detection 
wavelength of 270 nm showing the increase of the phenol peak and the decrease of the 
dexamethasone peak. The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure 3.8  Chromatogram of arbutin, phenol and dexamethasone at 289 nm showing that 
arbutin is the dominant peak at this wavelength. The chromatographic conditions used were: 
Brownlee C18 (100 × 4.6 mm I.D., 3 µm particle size) column, injection volume 10 µL, mobile 
phase methanol:water (50:50, v/v), and flow rate of 1.0 mL min-1. 
  
Three replicates of each of the seven standard solutions were prepared and each 
concentration was injected three times.  The calibration curves were constructed by 
plotting the peak area against the concentration.  Linear regression of the calibration 
data for each standard was performed by using Microsoft Excel 2010.  The linear 
regression graph of phenol is given in Figure 3.9.  All calibration plots with their 
residual plots can be obtained in Appendix C. 
Good linearity was observed for all the standards over the concentration range 
tested.  The results of the linear regression analysis and the limits of detection and 
quantification are given in Table 3.4. 
 The correlation coefficients of the different standards were all above 0.95.  The 
hydroquinone standard had the lowest correlation coefficient at 0.965 whereas 
dexamethasone had the highest at a value of 0.999.  The normal probability plots, line 
fit plots and residuals were constructed at the 95% confidence level. 
The residuals give the difference between the predicted value and the 
experimentally determined value.  The closer the values are to zero, the more close the 
linear regression is to the predicted values.  Regression also gives an idea of whether 
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assumptions that were made while making the calibration plot are valid.  A good 
regression is that which has residual values close to zero and with a random distribution. 
 
Figure 3.9  Calibration curve for phenol.  The blue diamond points depict the experimental data 
and the solid line shows the linear regression model fitted. 
Residuals for the calibration curves of phenol, niacinamide, benzoquinone and 
dexamethasone were found to be random.  The residuals of the calibration curve for 
niacinamide are plotted in Figure 3.10.  It can be seen that the smaller concentration 
show a better fit for the linear regression as they are closer to zero the larger 
concentrations.  The residual plots for phenol, benzoquinone and dexamethasone can be 
obtained in Appendix C. 
The residual plot for arbutin was random at high concentrations, however at 
concentrations below 100 mg L-1 all the residuals were below zero (Figure 3.11).  This 
could indicate the presence of systematic errors in the smaller concentrations. 
The residuals for hydroquinone gave a U-shape (Figure 3.12).  This indicates 
that the linear regression method is not valid for hydroquinone.  Therefore, the 























concentration did not fit the model as well as for the other standards and this was also 
reflected in the lower value of the correlation coefficient of 0.965 (Table 3.4). 
The limit of detection (LOD) is found by using the error of the slope of the 
analyte calibration curve at a specific confidence level [41].  It was determined by using 
the following equation: 
LOD = kSa/b 
where Sa is the error of the slope, b is the slope of the calibration graph. The value of k 
= 3 was used which is associated with the confidence level of 99.86% [42]. 
The value obtained gives the lowest concentration of an analyte that can be 
reliably detected by an analytical process [42].  The highest limit of detection was that 
of hydroquinone at 0.071 mg L-1, with the lowest that of dexamethasone at 0.0066 mg 
L-1. The other LODs where found to be in-between these values and can be found in 
Table 3.4. 
 The concentration amount below which an analyte cannot be quantified is 
known as the limit of quantification (LOQ).  It is associated with the limit of detection 
and the noise of the instrument.  Below the LOQ, it can be safely assumed that the 
analyte peak is due to noise.  This value is calculated by using the following equation 
[43] at a noise to signal ratio of 10. 
= 3.33 ×  
 The LOQs of the standards are reported in Table 3.4, which shows that 
dexamethasone has the lowest LOQ at 0.022 mg L-1.  Therefore, the lowest 
concentration of dexamethasone that can be quantified by using the HPLC method 
reported here is 0.022 mg L-1. 
Jeon et al. reported the LODs for niacinamide and arbutin as 0.12 and 0.75 mg 
L-1 respectively [44].  The LOQ was found to be 0.41 and 2.48 mg L-1 for niacinamide 
and arbutin respectively at 260 nm detection wavelength [44].  However, Lin et al. 
developed a method for quantifying niacinamide with a LOD of 0.07 mg L-1 [38].  
Desmedt et al., had a method that could quantify a number of SLAs simultaneously.  
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The LOD of niacinamide, arbutin, hydroquinone and dexamethasone were determined 
to be 0.03503, 0.02121, 0.29935 and 0.06555 mg mL-1 respectively [45].  The LOQ 
values were 0.05560, 0.05656, 0.89827 and 0.15732 mg L-1 for niacinamide, arbutin, 
hydroquinone and dexamethasone respectively [45]. 
The reported LODs for niacinamide are between 0.12 [44] and 0.03503 [45] mg 
L-1.  The value obtained for the method reported here is 0.029 mg L-1, making it better 
than that of any reported value thus far.  The LOQ of other methods were 0.41 and 
0.0556 mg L-1.  Niacinamide had a LOQ of 0.095 mg L-1.  This value is between the 
values reported in literature. 
Arbutin had a LOD and LOQ of 0.010 and 0.033 mg L-1 respectively.  Both the 
LOD and LOQ for arbutin are lower than reported values.  This method is able to detect 
lower concentrations of arbutin compared with other methods. 
 



















Figure 3.11  Residual plot for arbutin showing two different patterns. 
 





































Table 3.4  Results of regression analysis of the calibration data for hydroquinone, benzoquinone, arbutin, phenol, niacinamide and dexamethasone using 
HPLC.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm I.D., 3 µm particle size) column, injection volume 10 µL, mobile 
phase methanol:water (50:50, v/v), flow rate of 1.0 mL min-1 and detection wavelengths of 240, 270 and 289 nm. 
 Hydroquinone Benzoquinone Arbutin Phenol Niacinamide Dexamethasone 
Concentration range/mg 
L-1 
14.1 - 132.6 7.44 - 60.2 5.92 - 148 1.552 - 38.8 9.2 - 98 1.18 - 30. 40 
Regression equation y = 12248x y = 53075x y = 3693x y = 9371.4x y = 11819x y = 23348x 
correlation coefficient 
(R2) 
0.965 0.986 0.998 0.998 0.994 0.999 
Standard error of slope 
(Sa) 
287.94 468.14 12.328 27.533 112.50 51.391 
Limit of Detection 
(LOD)/mg L-1 
0.071 0.026 0.010 0.0088 0.029 0.0066 
Limit of quantification 
(LOQ)/mg L-1 
0.23 0.088 0.033 0.029 0.095 0.022 
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The LOD of hydroquinone was 0.071 mg L-1.  Gao et al. reported the LOD of 
hydroquinone to be 0.15 mg L-1 [46] and 0.2 mg L-1 [4], by using different sampling 
methods .  Garcia et al. had the LOD at 0.08 mg L-1.  All the values stated here are 
higher than that which was obtained by the HPLC method reported here.  The LOQ was 
also found to be 0.235 mg L-1, which is in-between the values reported in literature. 
For dexamethasone the LOD and LOQ were 0.0066 and 0.022 mg L-1 
respectively.  These values are much lower than those reported in literature [45]. 
Gao et al. had reported different LOD for phenol based on the method of sample 
treatment.  The LOD was found to be 0.5 [4] and 0.2 mg L-1 [46].  The LOD determined 
here is 0.0088 mg L-1 which is lower than those reported in literature. 
 The results reported in Table 3.4 indicate that the analytes of interest are 
sensitive to the HPLC method reported here, and are even better than some of those 
reported in literature.  The chromatographic conditions used for the HPLC method 
were: Brownlee C18 (100 × 4.6 mm I.D., 3 µm particle size) column, injection volume 
10 µL, mobile phase methanol:water (50:50, v/v), flow rate of 1.0 mL min-1 and the 
detection wavelengths on the PDA detector were 240, 270 and 289 nm. 
3.5 Determination of extraction time and solvent for samples 
The mobile phase and extraction time was determined in order to get the best 
extraction of the SLAs in the creams.  This was done by using the experimental method 
described in Section 2.4.5.  The results obtained were plotted into a graph (Figure 3.13) 
in order to easily interpret them.  The best extraction solvent was found to be 2-
propanol, followed by methanol, and 50% methanol in 50% water was found to be the 
least effective solvent for the extraction. 
The extraction method of analysis involves sonication of the sample for a 
particular period of time.  By using 30 minutes and 15 minutes the extraction time was 
also optimised to give the best SLA extraction.  It was found that the best extraction 
time was 15 minutes for 2-propanol and 30 minutes for both methanol and 50% 





Figure 3.13  Optimisation of the HPLC extraction solvent and time using a sample containing 
the SLA hydroquinone.  The HPLC column used was a Brownlee C18 (100 × 4.6 mm) column, 
the mobile phase 50% methanol in water (v/v) at a detection wavelength of 289 nm. 
The best extraction solvent was determined to be 2-propanol with an extraction 
time of 15 minutes.  There were problems encountered with the use of 2-propanol as an 
extraction solvent (discussed in Section 3.8.2), and it was therefore replaced with 
methanol.  The extraction time was still kept at 15 minutes. 
3.6 Recovery and precision 
The accuracy of the method was determined by performing a recovery test.  
Recovery was done for different amounts of samples to eliminate any bias in terms of 
the sample size.  A small, medium and large amount of sample was used in samples that 
did not contain the analyte of interest. 
The recoveries of the standards were different for each standard and also for each 
amount.  The recovery ranged from 70.1 to 227.1% with the lowest and highest 
recoveries coming from hydroquinone and arbutin respectively (Table 3.5).  The 
recovery obtained should always be lower than 100% as this is the maximum amount of 
the sample added.  Niacinamide, dexamethasone, arbutin and phenol had values which 
were higher than 100% recovery.  A trend was observed for dexamethasone, arbutin and 
niacinamide which indicated that as the amount of standard is increased, the recovery 
becomes closer to 100%.  This could be interpreted as that for best results in 
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dexamethasone, arbutin and niacinamide determination, higher amounts of samples 
must be used so as to obtain the best SLA extraction for the samples. 
Phenol had the highest recovery at the lowest amount added, but this recovery 
was 134.3 ± 39.6% which is above the amount added.  The lowest recovery for phenol 
was that of the medium amount of standard added.  This was the case for benzoquinone 
as well.  Hydroquinone had a low recovery of 70.1 ± 4.5% at the lowest amount of 
standard added (1.8 ± 0.2 mg L-1) and the highest recovery at the medium amount of 
standard added (see Table 3.5).  The method was found to be reasonably accurate and 
could therefore be used in the analysis of the real samples. 
Table 3.5  Recovery of standards added to SLCs and analysed by the proposed HPLC method (n 
= 3). 
Sample 
Amount of standard 
added/mg 
Amount of standard 
found/mg % Recovery 
Phenol 0.5 ± 0.1 0.6 ± 0.2 134.3 ± 39.6 
1.7 ± 0.1 1.6 ± 0.1 95.3 ± 5.7 
2.6 ± 0.2 2.5 ± 0.1 96.1 ± 7.0 
Dexamethasone 0.6 ± 0.1 0.7 ± 0.1 110.0 ± 19.2 
1.7 ± 0.1 1.9 ± 0.1 108.8 ± 6.3 
2.6 ± 0.1 2.6 ± 0.1 100.0 ± 7.3 
Arbutin 0.8 ± 0.1 1.7 ± 0.2 227.1 ± 16.0 
3.0 ± 0.1 4.1 ± 0.2 136.3 ± 2.1 
6.1 ± 0.3 6.5 ± 0.3 108.1 ± 7.3 
Hydroquinone 1.8 ± 0.2 1.3 ± 0.1 70.1 ± 4.5 
4.6 ± 0.3 3.6 ± 0.2 76.9 ± 1.1 
8.3 ± 0.2 6.1 ± 0.3 74.9 ± 1.8 
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Benzoquinone 1.0 ± 0.2 0.9 ± 0.3 88.4 ± 31.2 
2.4 ± 0.1 1.9 ± 0.1 79.8 ± 5.1 
5.1 ± 0.6 4.2 ± 0.7 82.1 ± 3.8 
Niacinamide 0.8 ± 0.1 1.0 ± 0.2 137.8 ± 33.6 
1.5 ± 0.1 1.7 ± 0.2 108.9 ± 11.9 
3.9 ± 0.1 3.6 ± 0.1 90.9 ± 1.6 
 
 Precision of the method was determined from the intra-day (same day) and inter-
day (over a period of three days) analysis.  Precision analysis expresses the closeness of 
the agreement between the average values obtained from repeated measurements.  It 
measures the relative errors of the instrument.  Precision is expressed as relative 
standard deviation. 
The intraday precision analysis is reported in Table 3.6.  The %RSD for 
hydroquinone, arbutin, phenol, niacinamide and dexamethasone were 0.71-1.93, 0.31-
12.98, 0.1-0.61, 0.07-1.08 and 0.18-1.20% respectively.  The inter-day precision was 
found to be 2.23-37.70, 1.60-4.20, 0.54-2.65, 0.14-1.18 and 0.43-2.58 %RSD for 
hydroquinone, arbutin, phenol, niacinamide and dexamethasone respectively (see Table 
3.7). 
The inter-day analysis for hydroquinone was high.  It was noticed that in the 
hydroquinone standard there was a presence of benzoquinone (Figure 3.14).  This could 
mean that the hydroquinone standard does not stay the same over time.  The longer it 
stays, the more unstable it is and the more benzoquinone is observed which then 
interferes with the hydroquinone analysis.  The intra-day analysis of hydroquinone was 
good and acceptable. 
The inter-day and intra-day values were different for each SLA.  The best 
precision was observed for phenol in the intraday analysis.  The best inter-day precision 
was that of niacinamide.  The values for intra- and inter-day were acceptable for all 
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standards except for the intraday of hydroquinone.  To ensure precision all standards 
and samples containing hydroquinone were prepared and analysed at the same time so 
as to minimise the decomposition of the hydroquinone.  The HPLC method developed 
gives precise results. 
Table 3.6  Determination of precision by using the intra-day analysis of the standards (n = 9). 
Compound Concentration/mg L-1 Intra-day/mg L-1 ± SD % RSD 
Hydroquinonea 2 1.87 ± 0.03 1.34 
 6 5.83 ± 0.11 1.93 
 24 22.52 ± 0.16 0.71 
Arbutin 12.92 12.97 ± 0.13 12.98 
 32.30 30.17 ± 0.43 1.44 
 63.18 60.77 ± 0.97 1.6 
 109.82 111.74 ± 0.35 0.31 
Phenol 4.10 4.65 ± 0.03 0.61 
 10.25 10.58 ± 0.03 0.26 
 18.45 19.50 ± 0.02 0.10 
 34.85 38.13 ± 0.14 0.35 
Niacinamide 9.80 9.48 ± 0.01 0.07 
 34.65 36.79 ± 0.24 0.66 
 68.60 68.35 ± 0.11 0.16 
 98.00 100.51 ± 1.08 1.08 
Dexamethasone 3.90 3.41 ± 0.04 1.20 
 9.75 8.68 ± 0.04 0.50 
 27.30 25.51 ± 0.06 0.23 
 39.00 38.06 ± 0.07 0.18 
a n = 5  
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Table 3.7  Precision analysis of proposed HPLC method by using the inter-day analysis (n = 9). 
Compound Concentration/mg L-1 Inter-day/mg L-1 ± SD %RSD 
Hydroquinone 18.45 14.98 ± 0.51 3.41 
 42.3 37.49 ± 0.84 2.23 
 94 99.18 ± 11.78 11.87 
 156 182.88 ± 4.44 2.43 
Arbutin 20.37 20.13 ± 0.43 2.15 
 61.11 59.42 ± 1.48 2.49 
 95.06 94.80 ± 2.09 2.21 
 135.80 135.29 ± 2.88 2.13 
Phenol 4.47 4.51 ± 0.03 0.77 
 13.41 13.39 ± 0.23 1.7 
 27.16 27.46 ± 0.24 0.86 
 38.80 39.27 ± 0.46 1.16 
Niacinamide 22.00 25.02 ± 0.12 0.46 
 40.05 47.86 ± 0.29 0.61 
 74.80 90.77 ± 0.25 0.27 
 89.00 109.07 ± 0.49 0.45 
Dexamethasone 4.44 4.49 ± 0.12 2.58 
 11.70 11.70 ± 0.10 0.89 
 21.28 21.04 ± 0.07 0.34 
 30.40 30.73 ± 0.29 0.95 
 
3.7 Determination of real samples 
 Skin-lightening creams obtained from the local shops where analysed.  
Qualitative analysis was done on a wide number of samples.  These samples were 
prepared and analysed by the proposed HPLC method reported here.  A total of 35 
samples where qualitatively analysed with the proposed HPLC method.  The 
chromatograms for these samples can be seen in Appendix D. 
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The samples which were found to contain SLAs and had good resolution of the 
analyte peaks were quantified.  It was found that 11 samples out of the original 35 could 
be quantified.  The results of the quantified samples can be obtained in Table 3.8. 
 From the samples analysed it was found that one sample contained phenol, five 
samples contained arbutin, and three samples contained benzoquinone and 
hydroquinone, whereas two samples were found to contain niacinamide.  The samples 
containing hydroquinone were found to also contain benzoquinone because the 
hydroquinone hydrolysed into benzoquinone.  The benzoquinone concentrations could 
not be quantified as they were not fully resolved at their detection wavelength of 240 
nm as seen in the chromatogram in Figure 3.15.  It was found that at this wavelength the 
peak for hydroquinone could also be observed and co-eluted with that of benzoquinone.  
Hydroquinone was quantified at a detection wavelength of 289 nm where benzoquinone 
absorption is low. 
 Hydroquinone has been banned in South Africa [2] and therefore the three 
samples containing hydroquinone are illegal in this country, but as seen from the results 
these products are still in circulation and sold without any medical prescription. 
 Phenol has been reported to have a minor degree of whitening effect and it is 
used as a 3-5% solution to disinfect the skin [4] and it has been banned in South Africa.  
Sample 1 was found to have 0.655 ± 0.026% (m/m) of phenol.  This means this sample 
by law should not be sold in South Africa as it has been banned. 
The amounts of arbutin found in the samples were found to be between 0.291-
2.498% (m/m). This range is below the allowed amount of arbutin which is said not to 
exceed (7% (m/m)) [3]. 
 The allowed amount of niacinamide in skin-lightening products has not yet been 
established. The amount of niacinamide in the samples was found to be 0.751 ± 0.025 
and 1.049 ± 0.225% (m/m) for sample 27 and 26 respectively. 
There were samples which were labelled to contain specific SLAs, but when 
those samples were analysed the specific agents stated on the label were not detected.  
Sample 24 was labelled to contain 2% (m/m) hydroquinone.  No hydroquinone was 
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detected upon analysis of this sample.  Although there are many other hydroquinone 
derivatives which are used in creams, because of the lack of standards they could not be 
identified.  Sample 24 could maybe have one of the derivatives of hydroquinone 
although the label said hydroquinone. 
 
Figure 3.14  HPLC chromatogram with PDA results of a hydroquinone (HQ) standard 
displaying the presence of benzoquinone (BQ) at 240 nm and at 289 nm where it interferes with 
the hydroquinone analysis.  The chromatographic conditions used were: Brownlee C18 (100 × 
4.6 mm I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water 
(50:50, v/v), flow rate of 1.0 mL min-1.  
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Table 3.8  Concentrations of SLA determined in commercial skin-lightening products available 
in the Durban market. 
Samples SLA detected concentration of analyte/%m/m %RSD 
1 Phenol 0.655 ± 0.026 0.039 
5 Arbutin 2.118 ± 0.039 1.820 
6 Arbutin 2.498 ± 0.073 2.912 
8 Arbutin 2.318 ± 0.035 1.491 
9 Arbutin 2.220 ± 0.114 5.130 
16 Arbutin 0.291 ± 0.026 8.900 
21 Benzoquinone NR* 
Hydroquinone 1.255 ± 0.070 0.056 
22 Benzoquinone NR* 
Hydroquinone 2.224 ± 0.019 0.009 
23 Benzoquinone NR* 
Hydroquinone 1.853 ± 0.029 0.016 
27 Niacinamide 0.751 ± 0.025 0.166 
26 Niacinamide 1.049 ± 0.225 0.214 




Figure 3.15  Chromatogram of sample 22 showing the co-elution of benzoquinone and 
hydroquinone at the wavelength of 240 nm.  The chromatographic conditions used were: 
Brownlee C18 (100 × 4.6 mm I.D., 3 µm particle size) column, injection volume 10 µL, mobile 
phase methanol:water (50:50, v/v), and flow rate of 1.0 mL min-1. 
 Samples 28, 29 and 30 were labelled to contain arbutin as a SLA.  The analysis 
of the creams produced no peak for arbutin.  The UV spectra of the peaks obtained in 
the creams did not match that of arbutin.  The sample was labelled to also contain paw-
paw extract. 
 From all the samples analysed no sample was determined to contain steroids.  
Although samples 5, 6, 7, 8 and 9 were analysed because they were giving patients side-
effects associated with steroid use.  Sample 35 was bought because it was labelled that 
it contained the steroid betamethasone dipropionate.  Extraction and analysis of this 
sample with the method developed did not show the presence of this steroid.  The 
method developed was determined to be active even for steroids by the good recovery 
(see Table 3.5 for recovery data) obtained for the steroid dexamethasone. 
 Samples 5, 6, 8 and 9 were labelled to contain a derivative of kojic acid, kojic 
dipalmitate.  The derivative was not analysed for because of the lack of a standard.  
Sample 7 was labelled to contain kojic acid.  Kojic acid could not be analysed because it 
was not detected when a standard was analysed. 
 The %RSD of the samples was between 0.009-8.900%. This shows that the 
method can be reproducible for the different samples with a good precision. 
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3.8 Problems encountered with HPLC 
HPLC analysis produces peaks that are symmetrical.  The peaks should not have 
shoulders if there is no co-elution with any other compound in the sample.  The column 
performance test which is discussed in Section 3.2 was done to see the performance of 
the instrument as well as of the column.  This test was done in between runs as time 
progressed during analysis. 
3.8.1 Contamination of HPLC tubing 
A column performance test mixture was injected and the separation of the 
standards was observed.  However, the peaks contained peak shoulders and this 
problem needed to be addressed (Figure 3.16).  The universal mixture contained (in 
their elution order): sodium chloride, benzene, toluene, ethylbenzene, isopropylbenzene, 
t-butylbenzene and antracine.  The column was cleaned by using 100% methanol to 
remove anything that could have been stuck to the stationary phase. 
 
Figure 3.16  Chromatogram of universal mixture showing peak splitting with the Perkin Elmer 
Brownlee analytical column, Pecosphere C18 (150 × 4.6 mm, ID.) with a 5 µm particle size, 
injection volume 6 µL, mobile phase methanol:water (70:30, v/v), flow rate of 2.0 mL min-1 and 
the detection wavelength of 254 nm. The peaks are A) sodium chloride, B) benzene, C) toluene, 
D) ethylbenzene, E) isopropylbenzene, F) t-butylbenzene and G) antracine 
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A no injection blank was also run as this gives an idea of where the impurity in 
the peak could be coming from.  The column was removed from the Shimadzu 
instrument and put into a Perkin Elmer series 200 instrument.  The column performance 
test mixture was run again and the peaks were observed to be symmetrical.  It was then 
determined that the Shimadzu instrument with the fluorescence detector was the 
problem.  It was suspected that the tubing of the instrument was contaiminated.  The 
tubing was cleaned by running several solvents through it.  The solvents used were 
water containing nitric acid, methanol, 2-propanol and tetrahydrofuran (THF).  The 
clean-up was done without installing the column.  The column was put back and the 
peaks symmetry was resolved.  The test mixture no longer had some of the components 
as they are volatile and evaporated, but from the observed peaks, peak symmetry was 
resolved. 
3.8.2 Problems encountered with the injector 
To make sure there was no sample carry overs, blanks were run before each 
sample run.  The blanks used were dependant on the solvent used for the sample 
preparation.  During the analysis of samples prepared by extraction with the solvent 2-
propanol, there were peaks observed in the blank after analysis.  The peak in the solvent 
grew bigger in intensity as the injection volume of the sample was increased.  A no 
injection blank was done and the column was determined to be clean.  The increase of 
the peak intensity with the injection volume increase made it safe to assume that the 
injector must be contaminated. 
The clean-up method involved the use of different solvents to purge the injector.  
High injection volumes of 2-propanol were also used to clean the injector.  The injector 
loop was removed from the instrument and cleaned by putting it in different solvents 
and sonication for an hour per solvent.  The solvents used were methanol, acetonitrile, 
2-propanol and hexane.  A range of solvents were used on order to cover a range of 
polarities. 
Sonication of the injector loop decreased the peak of 2-propanol.  The peak was 
noticed to be low in methanol and even lower in 50:50 methanol:water, v/v.  Purging 
the injector also decreased the peak intensity, but this did not always work.  It was 
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noticed during the purge that the solvent was not moving from the solvent reservoir to 
the instrument.  The purge only worked sometimes. 
After several blank runs of 2-propanol which did not get the instrument clean, the 
instrument was changed.  This meant that the fluorescence detector could no longer be 
used as the UFLC Shimadzu is only equipped with a PDA detector.  The peaks 
observed in the blanks were not UV-active and did not match any of the SLAs.  
Although this was the case, the extraction solvent was changed to methanol as a 
precaution that the UFLC Shimadzu also did become contaminated. 
The UFLC instrument was purged after each batch of runs to ensure no 
contamination.  It was ensured that rinsing liquid was always available and methanol 
was used. 
3.9 GC-MS analysis of standards 
Gas chromatography coupled with mass spectrometry was used to develop a 
method to separate SLA in SLPs.  The SLAs are mostly composed of phenolic 
compounds and steroids.  The GC-MS used for the analysis could only detect masses up 
to 550 m/z.  Phenolic compounds are not very volatile, therefore, to be analysed by GC-
MS they had to be derivatised. 
GC-MS was used for the qualitative analysis of SLAs in SLPs.  A method using 
BSTFA as a derivatising agent was used.  Pyridine was used as a solvent.  A mixture 
containing four standards was run.  The mixture contained resorcinol, hydroquinone, 
kojic acid, and arbutin (Figure 3.17).  The total ion chromatogram obtained had many 
peaks.  The peaks were then identified by using their mass spectra (Figure 3.18).  
Resorcinol, hydroquinone, kojic acid and arbutin peaks were identified. 
To further confirm the GC retention times of the observed peaks, each standard 
was run individually.  The retention time for resorcinol, hydroquinone, kojic acid and 
arbutin were 9.03, 9.17, 10.94 and 14.77 minutes respectively.  The GC chromatogram 
of arbutin contained a lot of peaks which could not be explained.  The individual 





Figure 3.17  Total ion Chromatogram of a mixture containing resorcinol (RC), hydroquinone 
(HQ), kojic acid (KA), and arbutin (PA).  The temperature programme was set as 50 °C held for 
2 minutes, then an increase of 20 °C min-1 to 295 °C then held there for 10 minutes.  The split 





Figure 3.18  Mass spectra of peaks separated by GC-MS A) resorcinol, B) hydroquinone, C) 
kojic acid and D) arbutin. 
Having been successful in obtaining a GC-MS chromatogram, further analysis 
of standards which contained an –OH group in their structures was done.  The –OH 
group is important for the derivatisation using BSTFA. 
Phenol, 4-hydroxyanisol, 4-propoxyphenol and 4-phenoxyphenol were found to 
have retention times of 5.391, 7.315, 8.401, and 10.402 minutes respectively.  N-acetyl-
L-cysteine was found to have two peaks to which the mass spectra did not coincide with 
its molecular mass. 
There were steroids which were run but no GC-MS chromatograms were 
obtained.  This means the steroids could not be derivatised.  The steroids analysed were 
hydrocortisone, fluticasone propionate, clobetasol butyrate, betamethasone 17, 21- 
dipropionate, triamicinolone acetonide, 6α-methylprednisolone acetonide, fluocinolone 
acetonide, dexamethasone, beclomethasone dipropionate, and momentasone fuorate. 
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Different samples were prepared and analysed by the method described in Section 2.5.2.  
It was found that none of the samples contained the SLAs of interest.  The GC 






In this study a number of skin-lightening preparations bought in the market in 
Durban were investigated.  Reversed-phase high performance liquid chromatography 
(HPLC) with both ultraviolet and fluorescence detection was used.  Phenolic and steroid 
standards were used to qualitatively identify the active ingredients.  A method was 
developed for the extraction of SLAs in the creams and also for their quantification by 
means of HPLC. 
A total number of 35 skin-lightening preparations were qualitatively analysed, 
and it was found that 11 samples had skin-lightening agents based on the standards that 
were used. Arbutin, phenol, benzoquinone, hydroquinone and niacinamide were the 
active ingredients found in some of the skin-lightening preparations.  An external 
method of calibration was used to prepare the calibration plots for hydroquinone, 
arbutin, phenol, dexamethasone and benzoquinone.  All standards had a linear 
calibration curve over the concentration ranges tested.  The correlation coefficients for 
the different calibration curves were all above 0.95.  The hydroquinone standard had the 
lowest correlation coefficient at 0.965 whereas dexamethasone had the highest at a 
value of 0.999.  The residual plots showed random distribution for dexamethasone, 
benzoquinone, phenol and niacinamide.  Arbutin exhibited a systematic error at low 
concentrations and random errors at high concentrations.  Hydroquinone had a U-shape 
pattern.  This meant that for hydroquinone linear regression was a poorer choice.  This 
is consistent with the low correlation coefficient obtained and the fact that it hydrolyses 
to benzoquinone. 
The limits of detection and quantification were calculated and hydroquinone, 
benzoquinone, arbutin, phenol, niacinamide and dexamethasone had limits of detection 
of 0.071, 0.026, 0.010, 0009, 0.029 and 0.007 mg L-1 respectively.  The limit of 
quantification for hydroquinone, benzoquinone, arbutin, phenol, niacinamide, and 
dexamethasone were 0.235, 0.088, 0.033, 0.029, 0.095 and 0.022 mg L-1 respectively.  
76 
 
This values were found to be in line with literature with some even better than those 
reported in literature.  Recovery tests were used to test the accuracy of the method. 
The recoveries ranged from 70.1 to 227.1% with the lowest and highest 
recoveries coming from hydroquinone and arbutin respectively.  The recovery obtained 
should be close to 100% as this is the maximum amount of the sample added. 
Niacinamide, dexamethasone, arbutin and phenol had values which were higher than 
100% recovery.  Intra-day and inter-day analysis was done to determine the precision of 
the method.  The method was found to be precise. 
The samples which were found to contain skin-lightening agents and had good 
resolution of the analyte peaks were quantified.  From the samples analysed it was 
found that one sample contained phenol, five samples contained arbutin, and three 
samples contained benzoquinone and hydroquinone, whereas two samples were found 
to contain niacinamide.  The samples containing hydroquinone were found to also 
contain benzoquinone because the hydroquinone hydrolysed into benzoquinone.  The 
benzoquinone concentrations could not be quantified as they were not fully resolved at 
their detection wavelength of 240 nm.  It was found that at this wavelength peaks of 
hydroquinone could also be observed and co-eluted with the benzoquinone.  The %RSD 
of the samples was between 0.009-8.900% which is acceptable. This shows that the 
method can be reproducible for the different samples with a good precision. 
GC-MS was able to separate some phenolic standards, but analysis of the samples 
did not detect any SLAs in the samples. 
There is a need for strict regulations with the sale of SLPs and samples containing 
phenol and hydroquinone, as found here are not allowed in South Africa and their sale 
should be stopped. 
4.1 Future plans 
The analysis of the samples should be done with liquid chromatography - mass 
spectrometry so that all peaks can be identified based on the mass spectra.  There is a 
need to improve the GC-MS method and the sample preparation so that SLAs can be 
extracted and analysed.  There are always new SLPs in the market, so further work 










Analysis of clays used by Xhosa and Zulu 







The skin is the largest organ that humans have, and it is important that it is 
protected from the harsh climate that we have in South Africa.  In particular in Durban, 
South Africa, the solar irradiance is high whether it is during winter or summer [47].  
With the beaches in Durban people tend to spend a lot of time outdoors enjoying the hot 
weather.  The skin needs to be protected from solar ultraviolet radiation because it 
causes a number of detrimental effects.  Regardless of the skin colour of a person, the 
skin needs to be protected. 
5.1 Solar UV radiation 
Sunlight is composed of ultraviolet (UV), visible and infrared electromagnetic 
radiation [48].  UV solar radiation is in a range between 290 to 400 nm and it is just 
shorter than visible light (400-700 nm) [48].  UV is divided into UVA (320-400 nm), 
UVB (280-320 nm) and UVC (200-280 nm).  UVC does not reach the earth as it is 
blocked by the stratospheric ozone.  The ozone absorbs most of the radiation with 
wavelengths below 310 nm [49].  UVA and some of the UVB however do reach the 
surface of the earth.  The amount of UVA and UVB that reaches the earth is enough to 
cause biological consequences to the skin and the eyes [48]. 
UV solar radiation is predominantly composed of UVA.  UVA penetrates the 
deepest into the skin.  It generates radicals, such as reactive oxygen species, which can 
damage membranes, DNA and other cellular constituents [49].  UVA is weakly 
carcinogenic and causes aging and wrinkling of the skin [48].  UVA is an important 
toxic factor from UV solar radiation [49]. 
UVB solar radiation is absorbed into the skin.  It is absorbed by DNA and 
proteins and it is enough to damage and kill unprotected cells [49].  UVB is more 
phototoxic compared to UVA [50].  It has been proven to be most effective in inducing 
skin cancer in animals [50].  In addition to this, UVB solar radiation also produces 
burns and erythema [48]. 
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The main cause of cancer has been the continuing exposures to sunlight [50, 51].  
It is therefore important that we are protected from the solar UV radiation.  Some of the 
ways to protect the skin from solar radiation include the use of a broad-spectrum 
sunscreens, wearing protective clothing and avoiding exposure to the sun.  The daily use 
of sunscreens to avoid acute skin damage is important as repeated damage to the skin 
may lead to photoaging and skin cancer [50, 51]. 
There are many sunscreens which have been developed throughout the years.  The 
research into safe and effective sunscreens is growing.  There is a need to find sunscreen 
agents that will protect the skin from both UVA and UVB.  Sunscreens that seem to be 
most effective and safe on the skin are very expensive, therefore, there is a need to 
develop cheap and effective sunscreen products. 
Women in South Africa spend a lot of time outside in the sun.  This is because of 
households chores which could include fetching water from the river and collecting 
firewood.  In the cities women also spend a lot of time outdoors working in the garden, 
selling as street vendors, and also working for the municipality whereby they sweep the 
city streets and collect garbage in the sun.  These women are mostly affected by the sun 
as they work in the sun the whole day.  The women have been using red and white clays 
on their faces to protect the skin from the harsh solar UV radiation.  The red and white 
clays are very cheap and can be bought from street vendors at about R10 per packet for 
a quantity of about 1 kg.  These clays can last them for long periods of time.  The clays 
are not only used as sunscreens.  In some cultures in South Africa clays are used during 
the initiation ceremony when boys are said to go into manhood.  The boys in the Xhosa 
tradition are covered in white clay all over their bodies during the ceremony.  Clays are 
also used for decorative purposes.  This can be seen in Xhosa women who paint dots on 
their faces with these clays. 
5.2 What are clays? 
Clay is a deposit which is distributed extensively over the surface of the earth 
[52].  Clays of different purity can be found everywhere.  They are rarely found in their 
pure composition, rather they can be found in large portions of impure clay [52].  The 
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definition was first formalised in 1546 by Agricola and has been revised many times 
since then [53].  Clays are produced by the decomposition of various rocks [52]. 
The term clay has been said to refer to naturally occurring material which is 
primarily composed of fine-grained minerals [54, 55].  This definition defines clays as 
naturally occurring and therefore would exclude all synthesised materials [53].  They 
are primarily inorganic materials excluding peat, muck, and some soils that contain 
large quantities of organic materials [53, 55].  Its characteristics are that it is generally 
plastic at appropriate water contents and hardens when dried or fired [54]. 
Clay has also been defined purely on the basis of particle/crystallite size, without 
compositional association [56, 57].  According to Hurst and Pickering, all definitions of 
clay have the common denominator of clay consisting of fine material which have 
particles finer than 74 µm [56]. 
The fine graininess of clay cannot be quantified because a specific particle size is 
not a property that is universally accepted by all disciplines [53].  Most geologists and 
soil scientists use particle sizes less than 2 µm whereas sedimentologists use 4 µm and 
chemists use 1 µm for clay particle size [53, 56, 57].  Engineers use 74 µm as the 
maximum particle size [56].  Clay is a term used by sedimentologists to denote a 
specific grain size only [53, 57]. 
From the chemical and mineralogical point of view clay can be defined as a finely 
divided rock that is composed essentially of clay minerals, usually together with smaller 
amounts of other crystalline and amorphous minerals besides organic matter [54, 56, 
57].  Clay minerals are composed of crystalline hydrated aluminosilicates and normally 
contain considerable amounts of iron, alkaline metals and alkaline earth metals [56, 57]. 
5.3 Characteristics of clays 
For a compound to be considered as clay the Association Internationale Pour 
L`étude des Argiles (AIPEA) have put up the following criteria: 
1) Natural, 2) fine-grained, 3) plasticity at appropriate water content, 4) hardening 
on drying and firing, and 5) containing phyllosilicates as principal constituents [54]. 
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Pure clay is composed of silicates of aluminium and when found in large 
quantities it is called kaolin [52].  Kaolin typically has the formula of 2SiO2, Al2O3, 
2H2O.  The pure composition of kaolin would be SiO2, 41.7%; Al2O3, 39.2%; H2O, 
13.7% [52, 58].  Impure clays contain feldspar such as orthoclase K2O, Al2O3, 6SiO2 or 
balbite Na2O, Al2O3, 6SiO2 and there will be also present mica having the formula K2O, 
3Al2O3, 4SiO2 and quartz SiO2 [52]. 
5.4 Examples of clays and their functions 
Kaolinite, smectite, palygorskite and sepiolite are the world’s most important and 
useful industrial clay minerals [59].  Their applications in industry are different. Their 
structure and composition give them different physical and chemical properties [59].  
Although kaolins, smectites and palygorskite-sepiolite have octahedral and tetrahedral 
sheets as their basic building blocks; their structures and composition are different [59].  
The difference in the clay properties of the clay minerals is based on the composition 
and arrangement of the octahedral and tetrahedral sheets [59].  This in turn affects their 
difference in applications. 
Some of the properties of the clay minerals that affect their applications are the 
particle size, shape and distribution [59].  Surface chemistry, surface charge and surface 
area are important properties of the clay minerals [59].  The application of interest will 
determine the many more properties of the clay minerals to be considered.  Clays and 
clay minerals in their applications are not just inert components but they are functional 
in the system [59]. 
5.4.1 Kaolins 
Kaolin is usually white in colour.  It has low base exchange capacity and minimal 
layer charge because it has very little substitution in the structural lattice [59].  The 
kaolin group of clay minerals is mostly composed of the mineral kaolinite (Figure 5.1) 
[56, 59]. The kaolinite crystals are pseudo-hexagonal along the plate, some larger books 
and vermicular stacks [59].  The geological conditions under which the kaolin is 
formed, the total mineralogical composition of the kaolin deposit, and the physical and 
chemical properties, are some of the important factors which influence their uses in 
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industry [59].  Kaolin deposits can be residual, sedimentary or hydrothermal and they 
all have different properties [59]. 
 
Figure 5.1  Diagram of kaolinite [60]. 
The largest use of kaolin is in the coating of paper [59].  Some of the other 
traditional uses include but are not limited to: cracking catalysis, pharmaceuticals, 
adhesives, crayons, ceramic ingredient and fibre glass [59]. 
5.4.2 Smectites 
The smectite group of clay minerals has several clay minerals, with sodium 
montmorrillonite and calcium montmorrillonite being the most important in industry 
[59].  They can have substitutions in both the octahedral and tetrahedral sheets therefore 
creating a charge imbalance in the 2:1 layer (see Figure 5.2) [59].  In the octahedral 
sheet, magnesium and iron substitute for aluminium [59].  In the tetrahedral sheets, 




Figure 5.2  Diagram of smectite layers [61]. 
Traditional applications of smectites include but are not limited to the following: 
pelletizing iron ore, bleaching clay, cosmetics, pharmaceuticals and animal feed bonds 
[59].  The applications are affected by the high layer charge, the thin flakes, high cation 
exchange capacity, very fine particle size and the high surface area, which determine the 




Palygorskite (Figure 5.3A) is a hydrated magnesium aluminium silicate mineral 
[59].  It is almost chemically and structurally identical to sepiolite (Figure 5.3B) except 
that sepiolite has a slightly larger unit cell [59].  Their applications include: suspension 
fertilizers, paper, paint, drilling fluids and as anticracking agents [59].  The major 
controlling physical property is its elongate shape [59]. 
 
Figure 5.3  A) Structural scheme of palygorskite [62] and B) structure of sepiolite [63]. 
5.5 Use of clays in cosmetics or for skin treatment 
The process of using clays for medicinal purposes has been around for many years.  
It has been reported that there are indications that ochres mixed with water and different 
types of mud have been used to soothe irritations, cure wounds, as a method of 
cleansing the skin, etc., by Homo Erectus and Homo Neanderthalensis [64].  This 
process of using clay minerals has been proven in ancient Egypt and Mesopotamia [64].  
Clay minerals are used for therapeutic purposes [64].  They are used in aesthetic 
medicine, pharmaceutical formulations and in spas [64]. 
Talc, palygorskite, smectites and kaolin are clays minerals that are used in 
pharmaceutical formulations.  These clays have a high specific area and sorptive 
capacity, chemical inertness, rheological properties and low or no toxicity for the 
patients which make them useful in pharmaceutical formulations [64].   
Clay minerals are used as what are called dermatological protectors. These are 
ointments, creams and powders used to protect the skin.  Kaolinite, smectites and talc 
are capable of adhering to the skin and form a film which protects the skin against 
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external chemical and physical agents.  This is due to their absorbent power.  They also 
absorb the skin’s secretions which results in having a refreshing action, creating a large 
surface for their evaporation which in turn promotes a gentle antiseptic action as it 
creates a water-poor medium, which is unfavourable for the development of bacteria 
[64].  This action is reinforced by the mineral’s capacity to absorb dissolved and 
suspended substances, such as greases, toxins and even bacteria and viruses [64].  
Clays have a high adsorbency level of toxins, grease, etc,. and as a result are used 
as active ingredients in cosmetics and face masks [64].  They are also used as 
antiperspirants and to give the skin opacity, remove shine and cover blemishes [64].  
Clay minerals are widely used in spas.  It is necessary to study the presence of toxic 
elements in the clay-water mix used in spas such as Hg, Pb, As, Sb, Cu, Zn, Cd, Se, etc. 
[64].  It is very important that their bioavailability is also studied to avoid possible 
intoxications [64]. 
 The UV protection of clays has been investigated by Hoang-Minh et al. [65].  
They investigated different clays in comparison to a sunscreen of SPF 20 [65].  It was 
shown that clays could absorb UV radiation without a need for additives [65].  The clay 
creams studied showed higher UV-transmission values than those of a commercial 
sunscreen of SPF 20 [65].  The clays that displayed high UV-protection potential were 
red in colour and were not well suited for sunscreen formulations [65].  Combination of 
the clays with a material that has favourable sunscreen properties was also investigated 
[66].  Clays combined with Ganoderma pfeifferi extract were examined based on their 
proctection ability against UV solar radiation [66].  The results showed that the 
mixtures had high UV-protection potential when compared with creams which did not 
contain the plant extract [66]. 
5.6 Aim and objectives of the project 
This project focused on the use of clays by women in South Africa on their faces. 
Beauty is one of the most important things to every woman; everyone wants to look 
beautiful and presentable. To a woman her skin, especially her face determines how 
people think about her when it comes to beauty, it is for this purpose that cosmetics are 
important. South African women have been wearing red and white clays on their faces 
as a form of cleansing product and also as a sunscreen. In this project the composition 
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of those clays was determined with respect to the minerals present in the clays and their 
influence on skin. The particle sizes of these clays were also determined to see if this 
has an effect on their light reflecting properties. In addition, the SPF of these clays was 
determined. 
5.6.1 Objectives 
 The composition of the clays was determined by means of X-ray fluorescence. 
 The composition of the clays was further identified by powder X-ray diffraction. 
 Confirmation of the phases and presence of the minerals in clays was done by 
means of infrared spectroscopy and thermogravimetric analysis. 
 Transmission electron microscopy was used to see the shape of the minerals in 
the clays. 
 The particle sizes of the clays were determined to see how suitable the material 
is for sun protection. 
 The sun protection factor of the clays was determined to see how effective these 
clays are as sunscreens. 
Chapter 6 will describe the experiments performed to characterise the red and 






Characterisation of these commonly used clays is important in order to determine 
their composition and thereby understand the way they function as sunscreens.  The 
composition and quantity of the elements in the samples was determined by using X-ray 
fluorescence (XRF).  The samples were further analysed by means of X-ray diffraction 
(XRD) to determine the minerals present and their phases.  Infrared (IR) spectroscopy 
was also used to further confirm the identity of the clay minerals present in the samples.  
Further confirmation of the clay minerals in the samples was obtained by 
thermogravimetric analysis (TGA).  The morphology of the samples was determined by 
transmission electron microscopy (TEM).  The particle size distribution of the samples 
was obtained by laser light scattering as the particle size affects the effectiveness of the 
clays in their use as sunscreens.  Additionally, the SPF values of the clays were 
determined at the Medunsa Photobiology laboratory. 
6.1 X-ray fluorescence 
X-ray fluorescence (XRF) is a technique used for the elemental analysis of a 
material.  Different materials can be analysed in the detection range of parts per million 
to 100% [67].  The materials can be in liquid, powder, solid, filtered or other form [67]. 
In XRF analysis materials are exposed to short wavelength X-rays or gamma rays 
[67].  Ionization occurs when an atom is exposed to radiation with energy greater than 
its ionization potential.  Ionization is the process whereby a material is exposed to 
radiation and it undergoes ejection of one or more electrons from its atoms [67].  When 
tightly held electrons are expelled, the electron structure of the atom becomes unstable 
[67].  There is a hole left behind, which is filled by the electrons in the higher orbital 
which fall into the lower orbital [67].  Energy in the form of a photon is released and 
this energy is equal to the energy characteristics of the atoms present [67]. 
88 
 
When absorption of higher radiation energy results in the re-emission of lower 
radiation energy the occurrence is called fluorescence [67].  Measuring the energies of 
the radiation emitted by the sample makes it possible for the qualitative determination 
of the elements present in the sample [67].  Quantitative analysis of the elements present 
in the sample is done by measuring the intensity of the energies emitted by the samples 
[67].  
6.1.1 Sample analysis 
Two clay samples (red and white) were submitted to the School of Agriculture, 
Earth and Environmental Sciences Geological Department for analysis. 
6.2 X-ray diffraction 
Materials such as clays are made of atoms in particular arrangements.  The 
knowledge of how the atoms are arranged into crystal structures and microstructures is 
the foundation of the understanding of the structure and properties of materials [68]. 
Powder X-ray diffraction (XRD) was done to determine the chemical composition 
of the clays.  This technique is powerful in phase identification and chemical analysis of 
the samples [69].  The technique involves the use of diffraction of X-rays.  To date, 
diffraction experiments have been used to gain knowledge on the spatial arrangements 
of atoms in materials [68]. 
One of the most important uses of powder XRD is for identifying unknown 
crystals in a sample of material.  This is because every crystal will always produce a 
unique pattern and in a mixture of substances the obtained pattern will be the 
combination of individual crystals in the substance.  This is done by matching the 
positions and intensities of the peaks in the sample diffraction pattern to a known 
pattern of peaks from a standard sample or from calculations [69].  The sample 
diffactogram can be matched by finger-printing.  The International Centre for 
Diffraction Data (ICDD, formerly the Joint Committee of Powder Diffraction 
Standards, JCPDS) holds a database of diffraction patterns from more than one hundred 
thousand inorganic and organic materials [69]. 
Software packages are available to identify peaks in the experimental diffraction 
pattern and then search the ICDD database to find candidate materials.  This is good 
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when a sample contains a mixture of phases and their chemical combinations are 
uncertain.  This has made XRD an important tool for identifying, quantifying and 
characterising minerals in composite mineral accumulations [70]. 
6.2.1 Instrumentation 
The instrument used was a XRD Bruker D8 Advance, equipped with a Cu Kα (λ= 
1.540 Å) source.  Diffractograms were collected over the 2θ range of 15- 90º. 
6.3 Infrared analysis 
The bond length between two atoms reported is the average bond length [39].  
This is because bonds in a molecule behave like vibrating springs, vibrating with both 
bending and stretching motions [39].  The bending vibration does not occur along the 
line of the bond and it changes the bond angles [39].  The stretching vibration changes 
the bong length and occurs along the line of the bond [39].  The bending and stretching 
vibrations occur with a characteristic frequency of a given bond [39]. 
Infrared radiation has frequencies which correspond to the frequencies of the 
bending and stretching vibrations [39].  When a molecule is exposed to radiation of a 
frequency that matches the frequency of one of its vibrations, it absorbs the energy [39].  
The bonds of the molecule will stretch and bend more due to the energy absorbed [39].  
The wavenumbers of the energy absorbed are determined to give the kinds of bonds 
present in the compound [39]. 
The spectrum obtained is a plot of the percent transmission of radiation versus the 
wavenumber of the radiation transmitted [39].  The instrument used to obtain the 
spectrum is called an infrared (IR) spectrometer.  
A Fourier transform IR (FTIR) spectrometer was used to analyse the clays.  This 
type of instrument has higher sensitivity and speed compared with the conventional IR 
spectrometer [39].  It simultaneously scans through all frequencies instead of 
sequentially scanning them; therefore this makes it more sensitive [39].  IR is often used 
in conjunction with other techniques to identify a compound.  IR is specific to the 
functional groups and bonds on a molecule.  There are libraries of compounds which 




The FTIR spectra of the clays were obtained with a Perkin Elmer Precisely FTIR 
spectrometer fitted with a Universal attenuated total reflectance (ATR) sampling 
accessory. 
6.4 Thermogravimetric analysis 
Thermogravimetric analysis (TGA) is a technique used to measure the mass of a 
sample as a function of temperature [71].  It is used to determine the fraction of volatile 
components in a sample and also determine the thermal stability of the sample by 
monitoring the weight change as the sample is heated.  The sample is in a controlled 
atmosphere such as air or in an inert atmosphere such as helium or argon [72]. 
The mass change of the material associated with the degradation and transition 
process can be quantified by using TGA [72].  TGA data provides characteristic curves 
for a given material because each material has its own unique pattern of reaction at 
specific temperatures [72]. 
6.4.1 Instrumentation and conditions 
The instrument used was the Universal TA Instruments Q600 thermal analyser. 
The samples contained in alumina pans were run under air at the flow rate of 50 
mL min-1.  They were heated from room temperature to 1000 ºC at a heating rate of 10 
ºC min-1. 
6.5 Transmission electron microscopy 
Transmission electron microscopy (TEM) is a tool that has been used widely to 
characterise different materials.  It is used to give information on the particle size, size 
distribution and the morphology of materials.  Some of the materials that have been 
analysed by means of TEM are metals, ceramics, polymers, alloys, glasses, 
semiconductors, wood, textiles and concrete [73]. 
TEM uses high energy electrons in a focused beam. The beam of electrons passes 
through a material, therefore scattering electrons.  Electromagnetic lenses are used to 
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focus the scattered electrons into an image.  Therefore this makes TEM have higher 
resolution compared with light-based imaging techniques. 
6.5.1 Instrumentation 
The instrument used for TEM analysis was a high-resolution transmission 
electron microscopy (HR-TEM, JOEL JEM-1010, Tokyo, Japan). 
6.6 Particle size distribution 
Clays are made of particles and the size of the particles is important.  The particle 
size distribution is important because it determines the possible applications and 
effectiveness of the material. 
6.6.1 Instrumentation 
The instrument used was a Malvern Instruments, Mastersizer 2000.  The 
instrument uses diffraction of laser light to measure the particle sizes.  A small sample 
of the clays was directly placed into the water of the instrument.  The clay particles are 
then dispersed in the water.  As the laser light passes through the dispersed particulate 
sample, light is scattered [74].  Measuring the intensity of the scattered light allows for 
the size of the particles to be calculated based on their scattering pattern [74] and the 
particle size distribution of the sample is obtained. 
6.7 Sun protection factor 
The sun protection factor (SPF) is used as an indicator of the efficiency of a 
sunscreen product to protect the skin against UVB radiation [75].  The food and drug 
administration (FDA) of the USA defines SPF as the UV energy required to produce a 
minimal erythema dose on protected skin divided by the UV energy required to produce 
minimal a erythema dose on unprotected skin [76].  Protected skin is that which there 
has been application of a sunscreen at 2 mg cm-2, and unprotected skin is skin to which 
no sunscreen product has been applied [76]. 
The SPF of the clays (red and white) was determined by the University of 
Limpopo Medunsa Campus, Department of Pharmacy and Photobiology Laboratory.  
An in vitro SPF testing procedure developed by Diffey and Robson was used to analyse 
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the clay.  The Optometrics SPF 290 analyser instrument was used.  The wavelength 
range of analysis was 290 to 400 nm. 






7 Results and discussion 
The clay samples obtained from the local river bank next to Inanda district in 
Durban were analysed by using different techniques.  It is of great importance to know 
the composition of the clays as these products are continually used by many South 
African women as a beauty care product and as a sunscreen.  Once the composition of 
the clays is known, their efficacy and any toxicity can be assessed.  The experiments 
conducted for the analysis of the clays are described in Chapter 6. 
7.1 Use of the clays 
Two clays are typically used, a clay which is white in colour and one which is red 
in colour.  The white clay is locally known as umcaku (IsiZulu/isiXhosa) and the red 
clay is called ibomvu (isiZulu/isiXhosa) [77].  The clays are used individually and the 
colour of the clays used by the women is a personal preference.  The clays for 
application are prepared by mixing the clay (100 g) with water (125 mL) and glycerine 
(20 mL) [77].  This produces a paste which is the applied to the face.  The appearance of 
women wearing the clays is shown in Figure 7.1. 
 




7.2 XRF analysis 
The major elements in the clays were determined by means of XRF.  The results 
are presented in Table 7.1 as weight percentages of the oxides.  The major oxides 
present were found to be those of silicon and aluminium.  The red clay was found to 
have a substantial amount of iron oxide compared with the white clay.  This was 
expected as the iron is responsible for the red colour of the clay.  The clays were found 
to have some titanium oxide which is used in sunscreens as a physical blocker (that is, 
to scatter and reflect incident radiation).  The clay samples also contained some other 
oxides in smaller amounts: these are MnO, Na2O, MgO, K2O, P2O5 and Cr2O3.  The loss 
on ignition was 10.58 and 24.46 wt% for the white and red clay respectively.  Loss on 
ignition (L.O.I) gives the loss of moisture and organics in the sample upon ignition.  
The results show that the red clay contained more organics compared with the white 
clay. 
Table 7.1  Major oxides present expressed as mass percentages of the white and red clays as 
determined by XRF. 
 
7.3 Powder XRD analysis 
Powder XRD was performed to determine the mineral phases present in the 
clays.  The mineralogy of the white clay interpreted from the XRD patterns shows that 
it is composed of kaolinite [Al2(Si2O5)(OH)4] as the dominant mineral phase and also 
some quartz (SiO2) (see Figure 7.2).  This was done by comparing the XRD pattern 
obtained with those previously reported [78-80].  The unique crystal structure of each 
solid phase of a compound allows for XRD to be used to identify them.  Each phase has 
a unique XRD pattern, which has resulted in libraries of spectra for ease of 
identification. 
The red clay was found to contain kaolinite [Al2(Si2O5)(OH)4], quartz (SiO2), 
hematite (α-Fe2O3) and maghemite (γ-Fe2O3) (see Figure 7.3).  Hematite and maghemite 
are iron oxides which are responsible for the red colour of the clay.  The XRD results 
SiO2 Al2O3 Fe2O3 MnO MgO CaO Na2O K2O TiO2 P2O5 Cr2O3 NiO Total L.O.I
White clay 63.4 32.85 0.49 0.000 0.200 0 0.02 1.13 1.525 0.02 0.086 0 99.7 10.6
Red clay 46.7 33.50 17.81 0.025 0.045 0 0.15 0.21 1.25 0.05 0.053 0 100 24.5
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are consistent with what was observed in the XRF.  The red clay can therefore be 
identified as iron-stained kaolinite.  
The diffactogram of the white clay was more clear and defined compared with 
that of the red clay.  This could be due to the crystallinity of the material.  The more 
crystalline the material, the sharper are the peaks in the diffactogram. 
7.4 Infrared spectroscopic analysis 
Fourier transform infrared spectroscopy (FTIR) was used to further identify the 
composition of the clays.  It was found that the red clay and white clay showed similar 
functional groups with just a few shifts in adsorption frequencies (Figure 7.4).  Peaks 
due to the Al2O3 of the kaolin were observed between 3950-3620 cm-1 [79, 81].  The 
white clay had two very weak peaks in the region between 2000-1600 cm-1 which were 
attributed to the presence of quartz [81].  The red clay had one peak in this region which 
was weak. 
Quartz and kaolin have doublets at 780-800 cm-1 which overlap each other [82].  These 
doublets where observed in both clays.  The doublet at 900-1000 cm-1 in both clays is 
due to kaolin [82].  Thus, FTIR confirmed the presence of the phases identified by 
powder XRD. 
7.5 Thermogravimetric analysis  
Thermogravimetric analysis (TGA) was performed to further identify the clays.  It 
was observed that the clays exhibited a loss in mass in the TGA curve just after 100 °C 
which is due to the loss of moisture in the clays (Figure 7.5).  Dehydroxylation of the 
kaolinite (Al2Si2O5(OH)4) to meta-kaolinite (Al2Si2O7) in the temperature range 400-
500 °C gives a weight loss in the TG curves and a rise to endothermic peaks in the DTA 
curve (Figure 7.5) [79, 83], these isotherms were observed at 507 ºC in the case of the 
white clay and 481 ºC for the red clay.  The red clay had a bigger loss in mass in the 
range 100-350 °C.  This may be attributed to the higher content of absorbed water in the 
red clay as compared to the white clay [83] and to the change of phases of the iron oxides 
in the red clay. Evaluation of the crystallinity of the samples can also be done by using 
the curves.  It can be deduced from the TGA graph that the white clay (Figure 7.5A) is 
more crystalline than the red clay (Figure 7.5B) by the weight lost at the temperature of 
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dehydroxylation (400-500 ºC) [79].  The DTA shows a sharper slope for the 
dehydroxylation of the white clay compared with that of the red clay which indicates 
that the white clay is more crystalline than the red clay [79].  This further confirms what 
was observed with the powder-XRD. 
7.6 Transmission electron microscopy 
The microstructures of the two clays were observed by means of transmission 
electron microscopy (Figure 7.6).  Kaolin has been shown to display pseudo-hexagonal 
structures [84, 85] which can be seen in the micrographs of the red and white clays 
shown in Figure 7.6.  The red clay has a less regular shape (see Figure 7.6B). This 
corresponds with what was observed with powder-XRD and TGA showing that it is not 
pure kaolinite and that the material is less crystalline. 
The kaolinite clays as identified above have been used in South Africa for a 
number of years.  Ekkose et al. has reported on kaolin deposits in Inanda (where the 
clays were obtained) and the Ndwedwe region which are close to each other [86].  The 
clays are mixed with water to make a paste which is then applied to the face as a mask.  
The use of geological minerals or clays for the therapy of skin is known as geotherapy.  
It has been known to treat dermatological diseases such as blackheads, spots, 
seborrhoea and many more [64].  Kaolinite is a good mineral to use as it is a good 
carrier and releaser of important minerals in the body.  This is due to its large surface 
area and adsorption capacity [87].  The effects of the clays can be observed by 
physically looking at the skin texture therefore making the skin more beautiful.  Silicon 
is found in kaolinite which is responsible for skin softness [88]. 
7.7 Particle size distribution 
The particle size distribution of the red and white clays was determined with a 
Malvern Mastersizer 2000 instrument that employs laser light scattering.  An average of 
three results was taken to produce the graphs shown in Figure 7.7 and Figure 7.8 for the 










Figure 7.3  Powder X-ray diffractogram of red clay showing kaolinite (K), quartz (Q), hematite 







Figure 7.4  Infrared spectra of A) white clay and B) red clay 
 
 





















































































Geologists and soil scientists use a particle size of less than 2 µm to define clays 
[53].  Clays are therefore expected to be uniform in terms of their particle size 
distribution. This is because they are mostly composed of particles of the same size.  
Consequently, it is expected that the particle size distribution graph will show the 
particles to be almost all the same size and the curve not to be broad. 
The results obtained show that the particles in our clay samples are not uniform.  
The red clay (Figure 7.8) has particle sizes ranging from 0.317 - ~2000 µm; with most 
of the clay particles ranging from 1.626 - 70.963 µm.  That is a very wide range for 
particles which are supposed to be of the same size.  The white clay (Figure 7.7) had 
particles sizes ranging from 0.448 - ~2000 µm; the range for most of the particles was 
between 1.416 - 1261.915 µm. 
 The samples were analysed as purchased by the customer and where not 
fractioned into components of more uniform sizes.  The particle size analysis results 
indicate that these samples should be more appropriately termed “river silt” (2-63 µm).  
The presence of the peak at larger particle sizes is indicative of the sand (quartz) present 
in these samples. 
 The white clay appears to be coarser than the red clay.  The particle size 
distribution for the white clay is very large and this can also affect how light is reflected 
by the particles. 
 The particle size of the clays is important when used as a sunscreen.  Their 
effectiveness as a sunscreen is due to the ability to reflect and scatter ultraviolet (UV) 
radiation from the skin surface.  The mechanism by which the sunscreen agents will 
protect the skin is different depending on the particles size.  Particles which are nano-
size absorb UV radiation while those that are pigmentary size (µm range) reflect and 
scatter the radiation [89].  The micron range of the particles in the clays makes them 
visible when applied to the skin.  Sunscreens which contain metal oxides do so in the 
micronized form with the particles in the nanometre range.  This makes the metal oxides 











Figure 7.6  TEM micrographs of A) white clay and B) red clay. 
 





Figure 7.8  Average particle size distribution of red clay. 
7.8 Sun protection factor 
The sun protection factor of the clays was determined according to the South 
African Bureau of Standards (SABS) sunscreen 1557 method by Dr Beverly Summers 
at the School of Pharmacy, University of Limpopo, Medunsa Campus.  The white clay 
displayed an SPF of 3.6, a UVA/UVB ratio of 0.9 and a critical wavelength of 387.6 
nm.  The red clay had an SPF of 4, a UVA/UVB ratio of 1 and a critical wavelength of 
388.9 nm.  The critical wavelengths of the clays were greater than 370 nm, which makes 
the clays to give broad-spectrum protection.  The red clay had smaller particle sizes 
which improves its light scattering and light absorbing ability and hence the marginally 
larger SPF value and critical wavelength.  Regardless of the low SPF values of the 
clays, they provide a degree of UVA protection.  UVA constitutes the greater amount of 
incident solar UV radiation and has been implicated in skin cancer.  To achieve good 
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sun protection, sunscreen formulators specifically pay attention to the particle 
dispersion of the material [77].  The home preparation of mixing the clays with water or 
glycerine makes particle aggregation a limiting factor in improving the SPF of the 
formulations. 
Application density is an important factor in sunscreen usage.  When testing 
commercial sunscreens, an application density of 2 mg cm-2 is used, but it is well known 
that typically usage patterns are less than half this amount.  With the use of the clays, it 
is unlikely to be the case because of the 100 g of clay mixed; about 5 g is used to cover 






 The clays used in South Africa provide a cheap way in which skin can be taken 
care of.  The clays are dug out of river beds for free and are sold at low prices without 
any further processing.  The clays have been identified as kaolinite and iron-stained 
kaolinite for white and red clay respectively.  Their SPF is low, but they do provide 
some UV protection.  The use of clays in cosmetics to enhance the sun protecting factor 
of the creams is continually being researched [65].  Clays are a natural alternative to the 
substances that are currently used in the market.  In addition, they do not suffer from the 
lack of photostability exhibited by some of the organic absorbers found in sunscreen 
products.  The safety and toxicity of these clays has not been determined, but those who 
use them have not reported any side-effects apart from the red colour that is left on the 
skin after the use of the red clay.  There is still, however, need for the safety and toxicity 
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Reagents used in Chapter 2 are listed here. 
Table A 1  Reagents used in the qualitative and quantitative analysis of SLAs with HPLC and 
GC. 
Chemical Grade Manufacturer 
Hydroquinone ≥99 % HPLC Fluka Analytical 
Resorcin 
 (1,3 dihydroxybenzol) 
 Riedel-de Haën 
p-benzoquinone ≥99.5 % (HPLC) Fluka Analytical 
N-acetyl-L-cysteine 99 % TLC, sigma grade Sigma 
p-arbutin ≥96.0 % (HPLC) Fluka Biochemika 
Kojic acid  Sigma 
Phenol 99.5 % (GC) Riedel-de Haën 
4-hydroxyanisole  
(4-methoxyphenol) 
99 % (GC) Sigma Aldrich 
Dexamethasone   
4-propoxyphenol 96% Aldrich 
Hydrocortisone   
Hydrochinondimethylether 
(1,4-dimethoxybenzene) 
99% (GC) Aldrich 
6α-methylprednisolone ≥98% Sigma Life Science 
Fluocinolone acetonide Minimum 98% Fluka Analytical 
4-phenoxyphenol 99% Aldrich 
Clobetasol propionate Minimum 98% Fluka Analytical 
Fluticasone propionate ≥98% (HPLC) Sigma Life Science 
Mometasone furoate ≥98% (HPLC) Sigma Life Science 
Betamethasone 17,21-
dipropionate 
 Sigma Life Science 
114 
 
Triamcinolone acetonide Analytical standard Fluka Analytical 
Beclomethasone 
dipropionate 
Analytical standard, for 
drug analysis 
Fluka Analytical 
Nicotinamide (niacinamide)  Supelco Analytical 
Betamethasone 17-valerate Analytical standard area 
99.6% (HPLC) 
Fluka Analytical 
Dexamethasone ≥98% (HPLC) Sigma Life Sciences 
Hydrocortisone Vetranal Area 98.7% (HPLC) Fluka Analytical 
Methanol Chromasolv for HPLC, 
≥99.9% 
Sigma Aldrich 
2-propanol 99.5%, HPLC grade Aldrich 
pyridine Analytical grade  






UV and fluorescence spectra of SLA standards 
The UV and fluorescence spectra of SLA standards determined.  The UV spectra 
were obtained by using a UV/vis spectrophotometer, and the fluorescence spectra by 
using a luminescence instrument.  All the standards were dissolved in methanol and 
methanol was used as a blank. 
B.1 UV spectra of SLAs standards 
 




















Figure B 2  UV spectrum of resorcinol. 
 








































Figure B 4  UV spectrum of N-acetyl-L-cysteine. 
 





































Figure B 6  UV spectrum of kojic acid. 
 







































Figure B 8  UV spectrum of 4-hydroxyanisole. 
 






































Figure B 10  UV spectrum of 4-propoxyphenol. 
 





































Figure B 12  UV spectrum of hydrochinon-dimethylether. 
 




















Figure B 14  UV spectrum of fluocinolone acetonide. 
 





































Figure B 16  UV spectrum of clobetasol propionate. 
 




































Figure B 18  UV spectrum of fluticasone propionate. 
 







































Figure B 20  UV spectrum of clobetasone butyrate. 
 






































Figure B 22  UV spectrum of dexamethasone. 
 







































Figure B 24  UV spectrum of beclomethasone dipropionate. 
 




































Figure B 26  UV spectrum of betamethasone 17- valerate. 
B.2 Fluorescence spectra of SLA standards 
 



































Figure B 28  Fluorescence spectrum of resorcinol. 
 


































Figure B 30  Fluorescence spectrum of N-acetyl-L-cysteine. 
 
































Figure B 32  Fluorescence spectrum of kojic acid. 
 




















Figure B 34  Fluorescence spectrum of 4-propoxyphenol. 
 
 






























Figure B 36  Fluorescence spectrum of dexamethasone. 
 




































Figure B 38  Fluorescence spectrum of hydrochinon-dimethylether. 
 



































Figure B 40  Fluorescence spectrum of fluocinolone acetonide. 
 




















































Linear regression and residual plots 
The calibration graphs of the standards analysed are presented here together with 
the residual plots. 
 
Figure C 1  Calibration curve for niacinamide.  The diamond points depict the experimental data 
and the solid line shows the linear regression model fitted. 
 







































Figure C 3  Calibration curve for phenol.  The diamond points depict the experimental data and 
the solid line shows the linear regression model fitted. 
 










































Figure C 5  Calibration curve for dexamethasone.  The diamond points depict the experimental 
data and the solid line shows the linear regression model fitted. 
 







































Figure C 7  Calibration curve for benzoquinone.  The diamond points depict the experimental 
data and the solid line shows the linear regression model fitted. 
 








































Figure C 9  Calibration curve for hydroquinone.  The diamond points depict the experimental 
data and the solid line shows the linear regression model fitted. 
 





































Figure C 11  Calibration curve for arbutin.  The diamond points depict the experimental data 
and the solid line shows the linear regression model fitted. 
 








































HPLC chromatograms of samples 
The HPLC chromatograms of all samples analysed are presented here. 
 
Figure D 1  Chromatogram of sample 1 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 2  Chromatogram of sample 2 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 3  Chromatogram of sample 3 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 4  Chromatogram of sample 4 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 5  Chromatogram of sample 5 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 6  Chromatogram of sample 6 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 





Figure D 7  Chromatogram of sample 7 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 8  Chromatogram of sample 8 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 9  Chromatogram of sample 9 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 10  Chromatogram of sample 10 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 11  Chromatogram of sample 11 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 12  Chromatogram of sample 12 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 13  Chromatogram of sample 13 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 14  Chromatogram of sample 14 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 15  Chromatogram of sample 15 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 16  Chromatogram of sample 16 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 17  Chromatogram of sample 17 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 18  Chromatogram of sample 18 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 19  Chromatogram of sample 19 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 20  Chromatogram of sample 20 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 21  Chromatogram of sample 21 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 22  Chromatogram of sample 22 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 23  Chromatogram of sample 23 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 24  Chromatogram of sample 24 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 25  Chromatogram of sample 25 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 26  Chromatogram of sample 26 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 27  Chromatogram of sample 27 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 28  Chromatogram of sample 28 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 29  Chromatogram of sample 29 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 30  Chromatogram of sample 30 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 31  Chromatogram of sample 31 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 32  Chromatogram of sample 32 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 33  Chromatogram of sample 33 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 34  Chromatogram of sample 34 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 




Figure D 35  Chromatogram of sample 35 showing the separation of components from the 
extracted sample.  The chromatographic conditions used were: Brownlee C18 (100 × 4.6 mm 
I.D., 3 µm particle size) column, injection volume 10 µL, mobile phase methanol:water (50:50, 






The GC-MS chromatograms were obtained using the GC-MS method reported.  The 
temperature programme was set as, 50 °C held for 2 minutes, then an increase of 20 °C 
min-1 to 295 °C then held there for 10 minutes.  The split ratio was set at 1:50. The 
injection volume used was 1 µL.  The column used was DB5 (30 metres). 
E.1 Standards chromatograms 
 












Figure E 4  Total ion chromatogram of derivatised arbutin. 
 




Figure E 6  Total ion chromatogram and mass spectrum of derivatised phenol standard. 
 










Figure E 9  Total ion chromatogram and mass spectrum of derivatised 4-phenoxyphenol 
standard. 
 




E.2 Sample GC chromatograms 
The chromatograms of the samples analysed will be displayed here. 
Table E 1  commercial skin-lightening creams analysed by means of GC-MS. 
Sample number Sample name 
1 BCO original skin repair cream 
2 Gentle Magic lotion 
3 unknown 
4 Beta cream 
6 Pure perfect parfait (7) 
7 Pure perfect parfait (8) 
8 Pure perfect parfait (24) 
9 Pure perfect parfait (25) 
10 Quick and clear blemish cream 
11 Bioclear vanishing cream 
12 Bioclear nourishing cream 
14 Skin spor G.S. 
15 Fair and white whitening cream 
16 Dabur Uveda complete fairness cream 
17 Fem bleach cream 
18 Fem post bleach 
19 Fem pre-bleach 
20 Magic amabala lotion 
23 Hypoderm cream with moisturiser 

















































































Figure E 30  Total ion chromatogram of derivatised SLC sample 26. 
 
 
